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ABSTRACT
Development and Characterization of Monoclonal Antisperm 
Antibodies: Potential for Contraception
Dilrowshan H. Hague 
Old Dominion University 
Eastern Virginia Medical School 
May, 1991
Directors: Drs. Nancy J. Alexander and Patricia A. Pleban
There is an expressed need to develop a greater variety 
of safe contraceptive methods which would find acceptance 
worldwide, particularly in developing countries. Immuniza­
tion against spermatozoa might be such a method as judged by 
the accumulated evidence from studies on human females and 
in a number of female animal species.
Two extraction techniques were used for sperm membrane 
antigen isolation. The first technique involved NP-40 
detergent for antigen extraction from human motile sperm and 
the second technique employed homogenized human testis for 
antigen extraction. Using these immunogens, sperm membrane- 
specific monoclonal antibodies (MAbs) were developed. When 
these antisperm MAbs were subjected to evaluation against an 
extensive panel of human tissues, no cross-reactivity to 
somatic tissues was observed, but staining was seen on sperm 
cells in testis, caput- and cauda epididymis, and vas defer­
ens. Four of these antisperm MAbs were against epididymal 
antigens, three were against seminal vesicle factors, and 
seven were against testis specific antigens. These
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evaluations indicated sperm specificity of these antibodies, 
fulfilling one of the important criteria for contraceptive 
vaccine development set forth in a World Health Organization 
(WHO) monoclonal antibody workshop report. The results of 
immunofluorescence (IF) and immunochemical staining (ICS) 
studies on methanol-fixed sperm indicated that these anti­
bodies recognized antigens on the plasma membrane overlaying 
different regions of the sperm, i.e., acrosome, post- 
acrosome, equatorial, midpiece, and tail. When these anti­
sperm MAbs were tested on fresh, capacitated, and acrosome 
reacted spermatozoa, a differential reactivity with fresh 
sperm as compared to acrosome reacted sperm was observed.
The wide species cross-reactivity of these antisperm anti­
bodies indicated shared antigens in these species, raising 
the possibility of employing experimental animal models to 
test contraceptive vaccines.
These antisperm MAbs demonstrated the multiplicity of 
antigens having a role in the process of fertilization.
Eight of these antisperm MAbs were able to inhibit at least 
one sperm functional test in vitro, which satisfied another 
criterion for immunocontraceptive vaccine development.
Since one MAb (DH22) was capable of binding to the acrosomal 
cap region of acrosome reacted sperm, this MAb could be used 
as a marker to identify acrosomal reacted sperm among the 
different matured stages found in a sperm population. 
Purification and biochemical characterization of these sperm 
antigens to which these antisperm MAbs were directed, would
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
be of interest to better understand their immunocontra- 
ceptive potential.
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CHAPTER 1
INTRODUCTION
The world population is increasing at an alarming rate. 
As we enter the 1990s, excessive population growth continues 
worldwide. The world population will increase to about ten 
billion in the 21st century and ninety-five percent of this 
global population growth is concentrated in developing 
countries (U.N., 1984). This continued growth means a 
severe scarcity of the available meager resources with a 
subsequent lowering of the standard and quality of living in 
these already poor countries. In light of the above, a 
continued search for safe, acceptable and reliable means of 
fertility regulation must be maintained and accelerated.
The following is a list of some contraceptive methods
currently in use for fertility regulation:
Steroidal contraception (oral or long acting) 
Intrauterine devices (lUD's)
Barrier methods (condoms, diaphragms etc.)
Spermicidal products
Vasectomy and female sterilization
To a large extent, the methods of birth control avail­
able at this time still do not satisfy all of the varied 
cultural and service demands of different populations.
There is an expressed need to develop a greater variety of
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
methods which would find wide acceptance, particularly in 
developing countries.
At present, vaccines are the greatest practical benefit 
that immunology has given humanity. After all these years, 
what is still essentially Jenner's vaccine against smallpox 
appears to have eliminated the disease worldwide. To date, 
most vaccines for human and animal health have been composed 
of whole organisms, viruses, or bacteria capable of inducing 
high levels of immunity over long periods of time. A birth 
control vaccine eliciting a specific, safe, low-cost, and 
effective antifertility immune response lasting for 1-2 
years would have a major impact in family planning programs.
The basis for a vaccine lies in the induction of a 
specific immune response to gamete or pre-embryo antigens.
In order to be effective, an antifertility vaccine requires 
that the antigen be unique to the reproductive tract and 
that the antigen have a fertility-related function. Thus, 
the antigen must be absent from other tissues, and it must 
have an action that can be blocked by an antibody or be 
located on a cell that can be lysed by complement. Efficacy 
and reversibility are two important criteria for an immuno- 
contraceptive vaccine. To be used for fertility regulation, 
a vaccine antigen must be expressed on the sperm surface 
(either an integral membrane protein or epididymal or 
seminal plasma-derived coating protein) and be accessible to 
immune attack. It must be immunogenic so that either alone
2
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or in concert with conjugated proteins or adjuvant, a sus­
tained and effective immunologic contraceptive response can 
be elicited. Furthermore, the antigen must be sperm 
specific so that no tissue damage occurs from cross-reaction 
(Anderson and Alexander 1983).
The possibility of inducing antibodies against repro­
ductive tract antigens by deliberate immunization was sug­
gested as early as 1899 by the pioneering work of 
Landsteiner (1899) and Metchinikoff (1899) , and immuno- 
contraception research has in recent years taken on new 
importance and such a great increase in activity. Experi­
mental immunocontraception approaches are directed at inac­
tivation of either one or more hormones, gametes, or pre­
embryo antigens.
The development of an effective contraceptive vaccine 
appears attractive in the male. Currently three possible 
immunogens are being considered. Two (gonadotropin-releas­
ing hormone and follicle stimulating hormone) are polypep­
tide hormones and the third (lactic dehydrogenase-C4) is a 
sperm-specific protein. Although sperm-specific antigens 
have been shown to be effective immunogens (Goldberg et al. 
1986) , their contraceptive efficacy has only been demon­
strated by immunizing females, and, as such, they do not 
qualify as a vaccine for the male.
A number of other immunogenic sperm specific antigens 
[acrosin, hyaluronidase, and rabbit sperm autoantigens
3
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(RSA-1)] have been identified and characterized. Such an 
approach would involve immunization of females. The feasi­
bility of this approach is based on two lines of evidence. 
The first line of evidence comes from numerous studies of 
human involuntary infertility which demonstrated that anti­
sperm antibody-mediated immunoinfertility reduces fertility 
in men and women (Menge, 1980). The second line of evidence 
comes from immunization studies of male and female animals 
of various species with sperm specific antigens. Immuniza­
tion with extracts of sperm or mature testis has been shown 
to result in a significant reduction of fertility, embryo 
failure, or pre-implantation embryo mortality (Edwards,
1964; Menge, 1970; Kiddy and Rollings, 1973).
Immunological Aspects of Contraception By Immunization
Infertility can be induced in experimental animals when 
they have been immunized against spermatozoa, seminal plas­
ma, testicular, oocyte, and trophoblast antigens. Theoreti­
cally, immunological factors would operate at any stage in 
the reproductive process (Fig. 1) since the gametes and the 
fertilized eggs, as well the hormones, tissues and other 
secretions in their environment, are all potentially anti­
genic and capable of eliciting an immune response. Fertili­
ty can be impaired in mammals by employing active or passive 
immunization against testis antigens, spermatozoa or seminal 
plasma in females (Mancini 1971; Tung 1980). The resulting
4
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FIG. 1 Some Immunological Antifertility Effector 
Mechanisms in the Male and Female 
Reproductive Systems
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antibodies seem to prevent spermatozoa from achieving fer­
tilization. Similar studies have also been carried out on 
males in attempts to destroy the seminiferous epithelium or 
to suppress the fertilizing ability of the spermatozoa in 
the male reproductive tract (for review see Shulman, 1971).
Spermatozoa, although immunologically foreign to women, 
usually do not stimulate humoral immune responses with 
coitus. Deliberate immunization of females with sperm can 
impair their fertility due to a combination of antisperm 
antibody effects. Intrinsic sperm antigens are produced 
during germ cell maturation in the testis (O'Rand et al.,
1981) or epididymis. Sperm coating antigens are added 
during sperm passage through the epididymis (Blaquier et 
al., 1986) and upon exposure to seminal plasma at ejacula­
tion. Antibodies to these intrinsic antigens and coating 
antigens are associated with unexplained infertility 
(Isojima et al., 1968). Clinical syndromes have been iden­
tified where male and female infertility almost certainly 
has arisen due to antibodies against spermatozoa (Ansbacher, 
1973; Alexander, 1983). Serum and cervical mucus from the 
female partner of infertile couples with poor postcoital 
test reports were tested (Dondero et al., 1978) against 
sperm from the normal male partner as well as sperm from a 
donor to see whether the infertility arises due to antibod­
ies against spermatozoa. Also vasovasostomized men fre­
quently have had antisperm antibodies in their seminal
6
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
plasma. Antisperm antibodies identified on the male part­
ner's sperm using both the immunobead assay and the radio- 
labeled antiglobulin assay have been associated with an 
inhibition of cervical mucus penetration (Fuchs and 
Alexander, 1983).
Various cellular responses and immunoglobulin classes or 
subclasses could be involved in the reactions leading to 
infertility. Investigations of infertile women have re­
vealed the presence of plasma IgG and IgM reactive with 
spermatozoa (Bronson, 1990). Antisperm antibodies of the 
IgM, IgG, and IgA classes may agglutinate sperm so that 
these sperm are unavailable to complete any further repro­
ductive functions (Franklin and Dukes, 1964). For example, 
this agglutination may prevent normal progress through the 
cervical mucus during transit in the female reproductive 
tract.
Immunity to sperm can compromise fertility by: (1) a
reduction in the number or quality of maturing sperm cells 
(Mancini et al., 1965); (2) interference with sperm motility 
(Mathur et al., 1984, 1986); (3) capacitation or the acro­
some reaction (Saling, 1986); (4) decreased penetration of 
cervical mucus (Fjallbrant, 1969; Kremer and Jager, 1976);
(5) enhanced phagocytic clearing of sperm from the female 
genital tract (Muscato et al., 1982); (6) sperm cytotoxicity 
given adequate levels of complement (Mathur, 1988);
(7) inhibition of sperm enzyme (Dunbar, 1976);
7
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(8) impairment of sperm-egg interaction (Saling et al., 
1985); (9) embryonic loss (Menge et al., 1982; Jones, 1976).
Since many of the vital events of sperm/egg interaction 
are associated with the sperm membrane, it is likely that 
antibodies to the membrane antigens may make ideal candi­
dates for immunocontraceptives.
Sperm Antigens
The sperm plasma membrane is a mosaic of antigenic 
domains. Many of them are only produced in male reproduc­
tive tract. Antibodies produced to these antigens may be 
responsible for reducing fertility in immunized animals. 
Normal fertile ejaculates contain spermatozoa and a fluid 
called seminal plasma. Upon ejaculation, the sperm surface 
is coated with the seminal plasma components, some of which 
are so tightly bound that they cannot be readily eluted by 
simple washing with physiological saline or organic solvents 
(Scacciati and Mancini, 1975).
Human spermatozoa can be divided into three parts: 
head, neck, and tail. The sperm head is composed of the 
nucleus and the surrounding membrane structures (Fig. 2).
The nucleus contains a haploid number of chromosomes and 
nucleoproteins, and it often has small, irregular shaped of 
clear areas referred to as nuclear vacuoles. The membrane 
structure of the sperm head consists of four parts: (1) the
plasma membrane that covers the entire surface of the sperm
8
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FIG. 2 Schematic Diagram of Human Spermatozoa
a. Normal spermatozoa showing 7 different 
regions
b. Cross section of human sperm head
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head; (2) the acrosome, a bag-like structure that surrounds 
the anterior portion of the nucleus; (3) the post nuclear 
cap, a cytoplasmic sheath that covers the posterior part of 
the nucleus; and (4) the equatorial segment.
Antigens of human sperm have been mapped and many re­
searchers report that naturally occurring human antisperm 
antibodies bind to antigens located on the acrosome, post 
acrosome, equatorial region, midpiece, and tail. Three 
types of semen specific antigens have been defined;
(1) antigens in seminal plasma; (2) sperm coating antigens 
(adsorbed epididymal and seminal plasma components on the 
surface of spermatozoa); and (3) genuine or intrinsic sper- 
matozoal antigens. The various groups of intrinsic sperma- 
tozoal auto- and iso-antigens are listed (Hjrot et al.,
1982) in Appendix, Table A.
The most potent sites for interfering with the fertil­
ization capacity of spermatozoa are likely to be on the 
outer and inner acrosomal membrane. Attachment of antibod­
ies to such sites would be expected to interfere with sever­
al crucial aspects of sperm function which include the 
vesiculation of the plasma membrane and subsequent release 
of soluble enzymes, as well as the binding of spermatozoa to 
receptor sites on the zona pellucida and oolemma.
Specific cell-cell contacts that occur during mammalian 
fertilization are probably initiated through non-covalent 
protein-protein and protein-carbohydrate interactions
10
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between surface membrane components (Fig. 3). Any compre­
hensive understanding of fertilization therefore requires a 
definition of these surface components and their chemical 
nature, localization on the cell surface and expression 
during gamete maturation and fertilization.
The Development And Changes Of Sperm Membrane Antigens 
During Spermatogenesis And Epididymal Maturation
Human spermatogenesis occurs in the seminiferous 
tubules at an average age of 13 years as the result of 
stimulation by anterior pituitary gonadotropic hormones. 
Figure 4 illustrates the various portions of the male repro­
ductive system associated with spermatogenesis and sperm 
maturation. During spermatogenesis, dynamic cellular inter­
actions take place. These are governed partly by initial 
recognition events involving plasma membranes of the cell 
within the seminiferous tubules. The expression of many 
sperm surface macromolecules occurs at a precise time in 
spermatogenesis.
1. Testicular Spermatozoa
In all mammals, including man, testicular spermatozoa 
are not capable of forward movement and are infertile. They 
are, however, similar in biochemical composition and struc­
ture to spermatozoa in other regions of the reproductive 
tract. Compared to ejaculated spermatozoa, testicular
11
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FIG. 3 Schematic Diagram of Sperm Plasma Membrane Components
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FIG. 4 Schematic Diagram of Portions of the Male 
Reproductive System Associated with
Spermatogenesis (TESTIS) and
Sperm Maturation (EPIDIDYMIS)
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TESTIS
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spermatozoa contain more proteins, sodium, calcium, and have 
a high rate of glucose oxidation and lactic acid production, 
high levels of neutral lipids and phospholipids and low 
levels of fatty acids and ATPase. Differences in the amount 
and composition of lipids in the plasma membrane of testicu­
lar spermatozoa may account for their higher charge density 
at the phospholipid-water interface of these spermatozoa, as 
well as for their higher membrane fluidity compared with 
that of epididymal and ejaculated spermatozoa.
Studies in animals reveal that testis-specific auto­
antigens appear on the late pachytene spermatocytes and 
persist through spermatogenesis (Millette et al., 1977). 
However, some antigens, which appear first on B spermatogo­
nia, are found at all stages of spermatogenesis, on sperma­
tids, and even on residual bodies, but not on mature sperm 
(Romrell and O'Rand, 1978). Additional antigens appear on 
the plasma membrane after the midspermatid stage of sper­
matogenesis (Romwell et al., 1978). Phelps and Myles 1987 
have reported that three monoclonal antibodies, PH20, PH21, 
and PH22, bind to the PH20 protein of guinea pig sperm.
They all bind to the entire surface of testicular sperm, and 
their binding sites are restricted to the posterior head of 
the cauda epididymal sperm. On the other hand, PH30 repre­
sents an antibody that does not bind to testicular sperm 
even though PH3 0 protein is present on testicular sperm. In 
this case the epitope recognized by the PH30 monoclonal
13
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antibody is not available on testicular sperm. Binding of 
this monoclonal antibody is first observed on cauda sperm 
where the antigen is restricted to the posterior head region 
(Primakoff et al., 1987). Similar human germ cell- and 
sperm-specific antigens, as revealed by mapping studies with 
monoclonal antibodies, develop during spermatogenesis 
(Anderson et al., 1987) and on the sperm surface during 
epididymal transit (Feuchter etal., 1981). The testicular 
sperm surface membrane is characterized by the presence of 
major species-specific high-molecular-weight proteins (105- 
115KD in the boar, Dacheux et al., 1989; 95-119KD in the 
ram, Dacheux and Voglmayr, 1983; 110-130KD in the rat, Jones 
et al., 1981; 110KD in man, Dacheux et al., 1987). Most of 
these testicular surface proteins gradually disappear in the 
first part of the epididymis. Some other compounds are 
removed very soon, such as 75-97KD compounds in the boar 
(Dacheux et al., 1989) and 78-88KD compounds in the ram 
(Dacheux and Voglmayr, 1983).
2. Epididymal Spermatozoa
The testicular spermatozoa and fluids pass to the 
caput region of the epididymis, then through the corpus 
portion into the cauda portion. Transport of the spermato­
zoa from the corpus to the cauda requires from one to three 
weeks. Spermatozoa, as they transit the epididymis, mature 
and gain fertilizing ability (Asch and DeCherney, 1987) .
14
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Sperm undergo changes in surface charge, surface carbohy­
drate composition, intramembranous particle distribution, 
plasma membrane fluidity, plasma membrane lipid composition, 
and surface protein and glycoprotein makeup during epididy­
mal maturation (Eddy et al., 1985; 1988). Changes in sur­
face charge can be observed by an increased binding of 
cationic colloidal iron particles, cationic ferritin, and 
positively charged beads (Olson and Danzo 1981). Spin 
resonance studies have detected a decreased charge density 
at the phospholipid-water interface. These changes in net 
surface charge probably result from a variety of additions, 
modifications and deletions of sperm surface moieties during 
epididymal maturation (Rodriguez-Rigau et al., 1982).
Changes in sperm surface carbohydrate composition 
have been observed during maturation and include decreases 
in the total bound sialic acid, and increases and decreases 
in the binding of various lectins to the sperm surface.
These changes appear to result from the addition and removal 
of saccharide moieties (Eddy 1988) . For example, galacto- 
syltransferase activity is present on the surface of the 
sperm and in epididymal fluid. This enzyme is required for 
mouse sperm binding to zona pellucida (Lopez et al., 1985).
Major changes in sperm surface protein and glycopro­
tein composition occur during maturation through (1) the 
addition of new components, (2) the unmasking or modifica­
tion of preexisting moieties, or (3) the loss of surface
15
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components. Changes in individual surface proteins or 
glycoproteins often occur within discrete regions of the 
epididymis, probably as the result of regionally specialized 
activities of the epididymal epithelium. The disappearance 
of sperm surface proteins is sometimes associated with the 
appearance of new proteins. Among the new membrane surface 
compounds of the sperm appearing during epididymal transit, 
most are characterized by a low molecular weight (range, 14- 
36K). Such events have been described in the.rat (Brown et 
al., 1983; Brooks and Tiver, 1984), the ram (Voglmayr et 
al., 1982, 1985), the hamster (Moore and Hartman, 1986), the 
chimpanzee (Gould et al., 1984), and the human (Dacheux et 
al., 1987) sperm.
During maturation, the sperm plasma membrane under­
goes changes in lipid content. There is a decrease in 
cholesterol, and there are significant decreases and in­
creases in a variety of plasma membrane lipids, but there 
are no significant changes in the cholesterol/phospholipid 
ratio (Nikoloupoulou et al., 1985). However, changes, in 
amount and composition may not occur uniformly in all re­
gions of the sperm plasma membrane during maturation. 
Freeze-fracture studies have demonstrated changes of intra- 
membranous particles within the plasma membrane during 
maturation, specifically in the acrosomal and post acrosomal 
region (Friend and Fawcett 1974). Expression of this matu­
ration phenomenon are manifested in the changes in antigenic
16
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properties of spermatozoa during epididymal transit as a 
result of the addition, substraction and modification of 
antigens on the cell surface (Tezon et al., 1985b; Eddy et 
al., 1988). Substantial progress in this area was achieved 
in recent years with the demonstration that androgen-induced 
glycoproteins secreted by the epididymis became associated 
with the surface of spermatozoa during maturation (Tezon et 
al. 1985a), Synchronous with this interaction, the cells 
developed the fertilizing ability which characterizes mature 
sperm. Major advances in characterizing the changes that 
occur at the sperm surface during epididymal maturation have 
come from the use of immunological tools to study this 
process. These approaches have been useful for demonstrat­
ing quantitative changes in the sperm surface during epidid­
ymal transit, for identifying new surface components that 
arise during epididymal maturation, and for determining 
where such components originate in the epididymis. Support­
ing evidence of a biological role of epididymal glycopro­
teins in maturation was obtained by using the alternative 
approach of blocking the biological activity of these anti­
gens with specific antibodies (Fournier et al. 1985).
Tezon et al. (1985) have shown that the antigens 
secreted by the proximal segments of the epididymis tend to 
accumulate in the epididymal plasma and on the spermatozoal 
surface as they pass through the organ. This finding sug­
gests a gradual incorporation of antigens from the
17
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surrounding milieu into the cells. Based on this observa­
tion, they extracted these antigens from the surface of 
ejaculated spermatozoa. A fraction corresponding to the 
proteins of epididymal origin was used to raise a polyclonal 
antiserum in rabbits. When incubated with sperm, the anti­
serum localized the antigens mainly on the acrosomal cap 
region of the ejaculated spermatozoon with minor localiza­
tion on the midpiece and flagellum. These researchers also 
showed that these epididymal antigens have a role on sperm- 
oocyte interaction. Blanquier et al. (1986) also suggested 
a significant relationship between infertility and defective 
antigen content or localization.
The Prefertilization Stages of Spermatozoa During Transit 
Through Female Reproductive System
The interaction and fusion of male and female gametes 
in the fertilization process is a multistep phenomenon that 
is still not well understood at the molecular and biochemi­
cal level. Immediately following coitus in primates and 
ruminants, spermatozoa encounter the cervical mucus, a fluid 
with complex physical properties. The physical properties 
of mucus contribute to several important cervical functions 
in these species, including exclusion of seminal plasma, the 
selective exclusion of certain sperm cells with morphologi­
cal and, possibly, functional abnormalities; and the
18
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retention and conservation of sperm for later migration to 
the upper tract.
During transit in the female reproductive tract, 
spermatozoa undergo physiological and biochemical changes 
during a process called capacitation. This process involves 
loss of sperm-surface molecules, including lectin and anti­
body-binding sites (Koehler, 1978; Schwarz and Koehler,
1979). Capacitation prepares the spermatozoa to undergo the 
acrosome reaction and the hyperactivated motility that may 
enhance the ability to penetrate the zona pellucida. Capaci­
tation has been described as a reversible process involving 
shifting and shedding of surface components of the plasma 
membrane acquired during epididymal transit and at ejacula­
tion (Weinman & Williams, 1964). During capacitation, there 
is a decrease in membrane cholesterol and a change in the 
phospholipid composition in the plasma membrane, thus alter­
ing the cholesterol/phospholipid ratio (Langlias & Roberts, 
1985). These alterations modulate membrane fluidity. The 
net negative charge of the membrane is reduced due to the 
removal of sialic acid residues (Farooqui, 1983) and sulfate 
residues (Langla et al., 1981) by hydrolases present in the 
female reproductive tract. Antisperm antibody H316 appears 
to bind to the human sperm acrosome only after capacitation 
and may be useful as a probe identifying capacitated sperm 
(Anderson et al., 1986). Antibodies directed against the 
plasma membrane of sperm can affect the mobility of membrane
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particles; thus impeding or possibly hastening capacitation. 
Support of this hypothesis comes from the finding that some 
antisperm antibodies exposed to sperm prior to capacitation 
prevent sperm fusion with hamster eggs (Alexander, 1984).
One end point of capacitation may be the hyper­
activation of sperm. This vigorous pattern of movement 
observed in capacitated sperm was first reported in the 
hamster in 1970 (Yanagimachi, 1970). Later it was reported 
in other species, including man (Burkman, 1984). These 
movements may enable sperm to overcome the physical resis­
tance of the vestments which surround the oocyte. When 
sperm antibodies directed against the plasma membrane affect 
sperm capacitation, they may inhibit sperm hyperactivation 
too. If sperm do not become hyperactivated, no penetration 
of zona pellucida or fertilization can occur (Fraser, 1981).
The end point of capacitation is the acrosome reac­
tion, an exocytotic event made up of a series of steps. The 
anterior region of the head swells and the outer acrosomal 
membrane fuses with the plasma membrane. The release of 
most of the acrosomal contents occurs next. Finally there 
is a loss of the shroud of the fenestrated membrane so that 
the inner acrosomal membrane becomes the external face of 
the sperm. Although it is still debatable whether the zona 
pellucida initiates the acrosome reaction, this oocyte 
vestment does provide the primary sperm contact during 
fertilization (Wassarman, 1988). Antisperm antibodies may
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mask the sites of induction of the acrosome reaction or 
reduce membrane mobility, and thus prevent its occurrence. 
Saling et al. (1986) reported that a monoclonal antibody 
directed against a sperm antigen prevents zona penetration 
by inhibition of the acrosome reaction.
During penetration, the spermatozoa must pass through 
the outer oocyte layers and arrive at the vitelline membrane 
in a state that is appropriate for fusion with this mem­
brane. A mature ovulated egg (Fig. 5) has three layers of 
outer vestments through which the spermatozoa must pass:
(1) the cluster of surrounding follicle cells, the cumulus 
oophorus, (2) the dense cellular layer present between the 
cumulus and the zona, the corona radiata, (3) the noncellu- 
lar coating known as zona pellucida. The major constituent 
of zona is glycoprotein. Antibodies can also impede sperm- 
egg fusion (Saling et al., 1985). Antibody directed against 
the zona can prevent sperm binding (Henderson et al., 1987; 
Sacco, 1987). In the rabbit and guinea pig, antisera to 
sperm membrane antigens interfere with zona binding and 
penetration (Primakoff et al., 1988; O'Rand, 1981). Anti­
sperm antibody in patient sera may also interfere with zona 
interaction ( Bronson et al., 1982; Tsuku, 1986; Mahony et 
al., 1991). Several studies have demonstrated that anti­
sperm antibodies can reduce hamster-egg penetration by human 
sperm (Alexander, 1984; Haas et al., 1980). Sperm penetra­
tion through the zona pellucida requires an initial period
21
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FIG. 5 A Mature Ovulated Human Egg With 3 Vestments Through Which The Spermatozoa Must Pass
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of time during which the spermatozoa attach and bind to the 
zona surface. This binding of spermatozoa to the zona is a 
tight, species-specific interaction and suggests that the 
zona pellucida may have sperm receptors on its surface. The 
putative presence of sperm receptors on the zona pellucida 
makes it likely that there are complementary egg-binding 
proteins. The murine zona pellucida is composed of three 
sulfated glycoproteins designated ZP1, ZP2, ZP3 (Bleil and 
Wassarman, 1980). ZP3, with a molecular weight of 83,000 
daltons, has been proposed as a species specific sperm 
receptor. Antibodies directed against these receptor sites 
could interfere with zona attachment and subsequent penetra­
tion. Recently researchers from our institute (Coddington 
et al., 1991) evaluated some monoclonal sperm antibodies to 
see if any antisperm antibodies could impede sperm-zona 
binding. Two monoclonals significantly decreased zona 
binding after exposure to MA-14 and MA-27. Another study 
from our laboratory (Mahony et al., 1991) evaluated 26 
antisperm monoclonal antibodies from a WHO (World Health 
Organization) panel with the hemizona assay. Among these, 
six monoclonals (S04, S19, S34, S58, S61, and S65) showed 
inhibition of zona binding (HZ index <50). Little is known 
about the mechanism of the binding process, it may bind to 
an intact plasma membrane, or a vesiculated surface, or an 
inner acrosomal membrane, or through a combined sequential 
reaction involving all three.
23
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Monoclonal Antibodies and Their Significance to Studies of 
Immunoreproduction
Antibodies produced from a cell line that has arisen 
from the growth and division of a single cell to form a 
clone are called monoclonal. Ever since the beginning of 
the experimental immunology at the end of nineteenth centu­
ry, scientists have explpited the specificity of antibodies 
to detect, isolate, and analyze biological material. The 
power of antibodies as probes for biological structure 
underwent a quantum increase in 1975, when Kohler and 
Milstein discovered a method for generating monoclonal 
antibodies. A number of hybridomas producing antibodies 
reactive against sperm have been developed. Monoclonal 
antibodies (MAbs) have proven to be highly useful probes for 
studying sperm surface components and for dissecting the 
structure and function of the male gamete. They have been 
used to map the domains of the sperm surface, to determine 
the time of appeairance of future sperm surface components 
during spermatogenesis, to examine the species specificity 
of antigenic determinants on the sperm surface, and to 
follow the fate of sperm components after fertilization 
(Eddy, 1988). MAbs have also been used to detect auto­
antigens and to test the role of surface components in the 
binding of the sperm to the zona pellucida and in fertiliza­
tion (O'Rand, 1981; Saling, 1986). Because these monoclonal 
antibodies permit the study of single sperm antigens,
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researchers have produced monoclonal antibodies that recog­
nize components of sperm from a variety of species including 
man (Lee et al., 1982; Isahakia and Alexander, 1984? Naz et 
al., 1984? Wolf et al., 1983). Human sperm antigens are 
being studied through application of sperm specific mono­
clonal antibodies and evaluation of their biochemical and 
functional characterization. These antibodies will provide 
insight into the mechanisms of immunological infertility as 
well as contributing to the development of contraceptive 
vaccines. The WHO Monoclonal Antibody Workshop identified a 
number of antisperm monoclonal antibodies that recognized 
functionally significant sperm antigens (Anderson et al., 
1987). The production of monoclonal antibodies directed 
against sperm provides a powerful tool for definition of new 
antigens that may be involved in fertilization.
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CHAPTER 2
LITERATURE REVIEW
Ever since Landsteiner (1899) discovered the antigenic 
properties of human spermatozoa, various investigators have 
studied the phenomenon of immunologic infertility. Early 
attempts have been made to induce infertility in females by 
immunization with whole spermatozoa and with seminal plasma.
In the last ten years, research has centered on using 
various antigens in purified forms to induce infertility in 
mice (Edwards, 1964), guinea pigs (D'Almeida and Voisin, 
1979; Primakoff et al., 1988), rabbits (Munoz and Metz,
1978), and primates (Goldberg, 1981). To be used for fer­
tility regulation, a vaccine antigen must be expressed on 
the sperm surface (either an integral or coating protein).
It is therefore logical to develop antisperm antibodies to 
sperm surface antigens. Definition of mammalian sperm 
surface domains at the molecular level has been achieved 
using lectins as probes (Schwartz et al., 1979), covalent 
protein labels such as [ 125l ]-diiodofluorescein isothio- 
cyanate (Herr and Eddy, 1980), polyclonal antibodies raised 
against sperm antigens (Herr and Eddy, 1980), and monoclonal 
antisperm antibodies (Myles, 1981; Schmell, 1982; Wolf,
1983) . Additionally, discrete patterns of intramembranous
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particle distribution in the plasma membrane have been 
defined by freeze-fracture replica techniques (Friend et 
al., 1977; Yanagamachi, 1990). At present, however, rela­
tively little is known about the association of such re­
stricted domains to cellular function. Characterization of 
the human sperm surface is in its infancy.
Studies of membrane antigens have been facilitated 
greatly by the availability of monoclonal antibodies to 
individual determinants of antigens in complex mixtures. 
Clones of antibody-producing cells can provide banks of 
antibodies for use in typing cells according to the antigens 
present on their surfaces, and sufficient quantities of 
antibodies can be produced readily to support antigen isola­
tion. The method for generating monoclonal antibodies has 
been used to develop a number of hybridomas producing anti­
bodies reactive against sperm from mouse (Saling, 1985a, 
1985b), rabbit (O'Rand et al., 1984) and guinea pig 
(Primakoff et al., 1988). Monoclonal antisperm antibodies 
are being used to study antigen expression during develop­
ment and differentiation in spermatogenesis and epididymal 
maturation in the mouse (Bechtol, 1979). A WHO-sponsored 
workshop, mentioned in the last chapter, was held to review 
the current status of monoclonal antibodies regarding their 
effects on molecular events underlying reproduction and the 
feasibility of using this approach to identify trophoblast 
and sperm specific antigens that might represent suitable
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candidates for contraceptive vaccine development. A list of 
66 mouse monoclonal antibodies reacting with human sperm 
submitted by 29 labpratories is shown in Appendix A 
(Anderson et al., 1987). The immunizing antigen in most 
cases was washed human ejaculated sperm or human sperm 
antigen extract; exceptions included S23-29 (purified mouse 
LDH-C4), S22 (baboon epididymal sperm), S12 and S57 (synge­
neic mouse sperm), S49 (rabbit sperm) and S60 (human chori­
onic villous surface membrane). S51 and S50 were two con­
trols reactive against sheep red blood cells respectively, 
and NS.l is a Ig-deficient ascites fluid produced by an 
unfused murine myeloma cell line. These antibodies were 
evaluated in coded form by 42 laboratories with the appro­
priate expertise in biochemistry, immunohistology and the 
testing of reproductive cell function. The majority of 
antisperm monoclonal antibodies cross-reacted with cellular 
elements in non-reproductive tissues. However, three anti­
sperm MAbs appeared to demonstrate sufficient specificity to 
warrant further investigation as reagents for the identifi­
cation of antifertility vaccine candidates. These three 
sperm monoclonal antibodies, S20, S37, and S61, were identi­
fied as primary vaccine candidates based on three criteria: 
(1) reactivity with human testicular germ cells and to the 
abundant surface antigens on mature spermatozoa; (2) minimal 
cross reactivity with somatic cells; and (3) inhibition of 
at least one sperm function assay (Lee et al., 1984; Moore
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et al., 1985? Herr et al., 1986). Although a panel of these 
monoclonal antibodies has been made from several animal spe­
cies, (Feutcher et al., 1981; Schmell et al., 1982? Isahakia 
and Alexander, 1984) only a few have been examined as to 
their effects on fertilization (Naz et al., 1984a; 1984b). 
Numerous human testicular germ cells and placental cDNA 
libraries are now available and provide a resource for 
cloning these vaccine candidates. To probe the library, 
monoclonal antibodies that can specifically affect fertil­
ization without cross-reacting with normal somatic cells are 
required.
The Characterization of Sperm Surface Antibodies
A. Sperm Functional Analysis
Two tests are commonly used to detect free antisperm 
antibodies, the sperm agglutination test (Kibrick et al., 
1952) and the sperm immobilization test (Isojima et al., 
1968) . Sperm-agglutinating antibodies are most commonly 
found in vasectomized men (65%) ; sperm-immobilizing antibod­
ies are found in 40% of vasectomized men (Ansbacher, 1971). 
Agglutinating antibodies are found in less than 10% of the 
infertile women, whereas sperm-immobilizing antibodies are 
found in about 8%. This agglutination and immobilization may 
prevent normal progress through the cervical mucus during 
transit in the female reproductive tract. Complement depen­
dent immobilization may result in damage to both the
29
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
acrosome membrane and the entire plasma membrane 
(LeBouteiller, 1975). Antisperm antibodies of the IgM and 
IgG classes may agglutinate sperm (Ingerslev et al., 1979) 
but only IgM and some subclasses of the isotype IgG are able 
to immobilize sperm by initiating the classical complement 
cascade (Brown et al., 1984). Antibodies of isotype IgA do 
not fix complement so they cannot immobilize sperm.
Recently an immunobead test involving micrometer-sized 
polyacrylamide beads coated with covalently bound anti­
immunoglobulin antibody was developed for the detection of 
antisperm antibodies to sperm surface membrane antigens 
(Bronson et al., 1984). This assay can provide information 
on the location of the antibodies on the sperm surface (for 
example, on the head, tail, midpiece or tail-tip) and immu­
noglobulin class G, M or A (Bronson et al., 1981; 1982).
Many monoclonal antisperm antibodies exhibit actions and 
specificities similar to those of naturally occurring anti­
sperm antibodies in human beings; for example, one has been 
reported that causes complement-dependent immobilization but 
not agglutination of human sperm (Isahakia & Alexander,
1984). A monoclonal antisperm antibody may cause neither 
sperm agglutination nor sperm immobilization but prevent 
gamete interaction. There are some in vitro and in vivo 
tests which can be used to detect any inhibition of sperm 
egg interaction due to antisperm antibodies. The first 
interaction of the spermatozoon and egg involves tight
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binding of spermatozoa to the zona pellucida. This highly 
species specific binding involves complementary sites on the 
receptors of the surface of the gametes (Ahuja, 1985)• The 
irreversible binding of sperm and zona necessary for fertil­
ization and some types of male infertility have been 
demonstrated to be due to failure of spermatozoa to complete 
this adhesion (Overstreet et al., 1980). Overstreet et al. 
(1976) first suggested the use of zona intact non-living 
oocytes to examine the sperm-zona pellucida binding.
Burkman et al. (1988) at our Institute have further modified 
this hemizona assay (HZA) technique. The HZA is being used 
as a clinical tool to evaluate patients and is predictive 
for fertilization potential (Franken et al., 1989b). The 
hemizona assay can be used to evaluate whether antisperm 
antibodies impede binding. When sperm were coincubated with 
antibody for one hour, some monoclonal antisperm antibodies 
markedly inhibited binding, thus providing evidence that 
such antibodies could potentially reduce fertility (Mahony 
et al., 1991).
The zona-free hamster penetration test (SPA) has been 
used extensively in many laboratories to examine the role of 
antisperm antibodies in fertilization. Our laboratory 
(Alexander et al., 1983) and others (Haas et al., 1980; Dor 
et al., 1981) have observed that antisperm antibodies, espe­
cially of the IgG isotype, interfere with human sperm pene­
tration of hamster egg membrane. When sera from patients
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with immunologically-mediated infertility were exposed to 
normal sperm, the ability of their sperm to penetrate ham­
ster eggs was much reduced or eliminated. A penetration 
rate of 59% was observed for the control sera as compared to 
only 15% for the test sera. Fully 90% of the sera from 
patients with antibodies to sperm caused a reduction in egg 
penetration rates.
Antisperm antibodies can significantly inhibit in vitro 
fertilization of mouse eggs by murine sperm (Naz et al., 
1984a). In vivo (by passive immunization) fertilization can 
be used (Naz et al., 1984a; Saling and Waibel, 1985) on 
animal models for primary evaluation of fertility effects 
due to antisperm antibodies. Immunization with an anti- 
idiotypic antibody which mimics sperm antigen structure 
could be completed (Carron et al., 1988). The mouse mono­
clonal antisperm antibodies M42.14 and M29.6 recognized 
distinct mouse sperm antigens which prevented mouse fertil­
ization in vitro and in vivo (Saling, 1986). There are 
several advantages associated with the application of human 
antibodies for passive immunization using animal models to 
test their effect on fertilization: (1) They are a cheap
source of unlimited amount of well characterized and sero­
logically very specific reagents; (2) The degree of immuni­
zation is directly proportional to the amount of the anti­
body applied, and does not depend on individual variation 
response; (3) The action is shortlived and is. fully
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reversible; (4) As they are human proteins, severe immuniza­
tion against other cells do not seem to be probable even if 
they are applied several times sequentially.
B. Biochemical Characterization
Western blot techniques have revealed that, even 
though an antibody reacts to what appears to be the entire 
acrosome, antigens of differing molecular weights may be 
involved. Primakoff and Myles (1983) have found guinea pig 
sperm head antigens ranging from 18 to 70 Kd, and our labo­
ratory has observed human sperm acrosomal antigens varying 
from 34 to 240 Kd. In elegant studies, Reynolds and 
Oliphant (1984) have used monoclonal antibodies to charac­
terize an acrosome-stabilizing factor, a 360 Kd dimer syn­
thesized in the corpus epididymides and found in seminal 
plasma and caudal epididymal fluid. This substance main­
tains the acrosome during epididymal storage and prevents 
the acrosome reaction.
As was mentioned, during the fertilization process, 
the sperm cell must successfully interact with two primary 
surface constituents of the egg, the zona pellucida (an 
extracellular glycoprotein.layer that surrounds the egg) and 
the egg plasma membrane. Sperm-zona interaction involves 
the binding of the sperm to species-specific receptor mole­
cules present within the zona (O'Rand, 1988). A number of 
studies have indicated that carbohydrate moieties present
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within the zona pellucida or on the surface regulate this 
interaction. Competitive inhibition studies using various 
monosaccharides, polysaccharides or glycoproteins have 
indicated a role for specific carbohydrate moieties in 
mediating sperm-zona interaction in hamsters (Ahuja, 1982) 
and mice (Wasserman and Bleil, 1982). Treatment of either 
the zona pellucida or sperm with glycosidic enzymes also 
inhibits sperm binding to the zona in a variety of species 
(Ahuja and Gilbert, 1985; Shur and Hall, 1982). The possi­
bility that sperm-egg fusion involves carbohydrate compo­
nents of the sperm and/or egg plasma membrane is suggested 
by observations in other membrane fusion systems where 
glycoproteins play a critical role in the fusion process. 
Once these antigens have been elucidated, they can be used 
both in infertility assessment and production of a contra­
ceptive vaccine.
Lectins, such as concanavalin A and wheat germ agglu­
tinin, are plant proteins that have multiple binding sites 
for specific sugars. Wheat germ agglutinin, for example, 
binds to glucose and mannose. Most plasma membrane glyco­
proteins have multiple exposed sugar groups; thus, lectins 
cross-link glycoproteins that have multiple appropriate 
sugar substituents. Monoclonal antibodies against sperm 
membrane glycoproteins often react with antigenic determi­
nants common to more than one cell-type, and such
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cross-reactivity is mainly due to glycoconjugates on the 
cell surface (Anderson et al., 1987).
Production and characterization of antisperm monoclonal 
antibodies will aid in understanding fertilization and be a 
step toward contraceptive vaccine development.
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CHAPTER 3
SPECIFIC AIMS
Specific aims of this project are to
1. Develop murine monoclonal antibodies directed against 
human sperm surface antigens.
a. Prepare sperm membrane (both coating and integral) 
antigen extraction from human ejaculated sperm and 
from human testicular sperm.
b. Immunize Balb/c mice
i. by conventional immunization technique and
ii. by first tolerizing mice with common antigenic 
sugar moieties to human sperm and somatic cells
and then immunize mice with human sperm
extracted antigens.
c. Perform the classical hybridoma technique to
generate Mabs against extracted sperm surface
antigens.
d. Determine the class (isotype) and quantitate 
antibodies.
2. Localize antigens reacting with a particular MAb 
restricted to the sperm surface on human by
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immunofluorescence (IF) and immunochemical stain­
ing (ICS) .
3. Determine the molecular weight of antigens from 
extracted sperm antigens that are recognized by these 
MAbs by the immunoprecipitation technique and SDS-PAGE 
(sodium-dodecyl sulfate polyacrylamide electrophoresis)
4. Determine the reactivity of MAbs with fresh, capacitat­
ed, and acrosome reacted human sperm by enzyme linked 
immunosorbant assay (ELISA) and ICS.
5. Determine whether these MAbs are against human sperm 
surface antigens by the live sperm ELISA and the immuno 
bead test (IBT).
6. Perform cross-reactivity studies evaluating generated 
panel of MAbs using ELISA /or CB-RIA (cell-binding 
radioimmunoassay) to sperm and other cell types (human 
lymphocytes, erythrocytes) or do IF and ICS against a 
panel of human tissues.
7. Localize the origination of sperm antigens in the repro 
ductive system reacting with a particular MAb by IF and 
ICS on frozen human reproductive tissue section.
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8. Determine the cross reactivity of MAbs with other
species spermatozoa by IF and ICS.
9. Determine whether these antisperm antibodies have
functional significance.
a. Sperm agglutination assay (SA)
b. Sperm immobilization assay (SI)
c. Cervical mucus penetration assay (CM)
d. Hamster egg penetration assay (SPA)
e. Hemizona assay (HZA)
10. Determine whether a carbohydrate moiety is involved on 
the sperm surface antigen activity by means of inhibi­
tion of carbohydrate moiety by sodium metaperiodate.
11. Use passive immunization of any particular promising 
antibody that also cross-reacts with mouse sperm to 
determine whether a reduction in fertility occurs.
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CHAPTER 4
PURPOSE & SIGNIFICANCE
At present, no group of sperm antigens useful for 
human immunocontraception has been defined. The current 
literature shows that the majority of extant monoclonal 
antibodies cross-react with cellular elements in nonrepro- 
ductive tissues.
For vaccine development, the reactivity to the abun­
dant surface antigens on mature spermatozoa and the minimal 
cross reaction with somatic cells are important criteria 
(Anderson et al., 1987). Therefore, the aim of our study is 
to develop antisperm monoclonal antibodies to sperm membrane 
surface antigens.
One approach is to use human sperm membrane prepara­
tions. This requires the definition of specific epitopes 
that will not cross-react with other tissues but which 
result in an effective and reversible mode of contracep­
tion.
Lectin binding studies of sperm membrane extracts 
have identified abundant amounts of 4 sugar moieties (mann- 
ose, galactose, N-acetyl-glucosamine, and fucose) which are 
common to many cell types (Kurpisz et al., 1989). Thus, it 
is not surprising that antisperm monoclonal antibodies often
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cross react with antigenic determinants common to more than 
one cell type (Waibel et al., 1987; Anderson et al., 1987; 
Tsuji et al., 1988). In our proposed study we used a toler- 
ization protocol to see if by tolerizing the mouse with 
these common sugar moieties, we can prevent the cross­
reactivity with other cells; hence, we can develop more 
sperm specific monoclonal antibodies. This approach may 
also facilitate producing antibodies against surface pro­
teins that are weakly immunogenic, even though these anti­
gens may be involved in fertilization.
Seminal plasma-derived coating proteins and antigens 
are expressed not only on sperm but may also be present on 
somatic cells. These antigens often appear to be more 
immunogenic in the mouse than the gamete-specific compo­
nents. In order to eliminate the reactivity to seminal 
plasma-derived coating protein, we also used an extract of 
human mature testicular tissue to immunize mice.
Antisperm antibodies that inhibit zona binding are 
also an area of interest in contraceptive research. In 
nonhuman models, antibodies to sperm antigens can inhibit 
fertilization by preventing zona binding (O'Rand, 1981). 
Whether the results obtained from animal studies can be 
applied directly to the human system is not yet clear. The 
new hemizona assay has been used as a clinical tool to 
evaluate patients and predict their fertilization potential. 
Our laboratory has presented data (Mahony et al. 1991)
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showing that some antisperm monoclonal antibodies can inhib­
it zona binding as determined by the hemizona assay, 
although the antibodies may not inhibit any of the sperm 
functional assays other than hamster egg penetration. One 
aim of this study is to screen our antisperm monoclonal 
antibodies using this new hemizona assay.
The purpose of this study is to develop highly spe­
cific antihuman sperm MAbs and to characterize some that are 
functionally significant, so that in future study, these 
could be used in a cocktail of significant antisperm mono­
clonal antibodies to evaluate a cDNA library for production 
of sperm antigens in vitro. Definition and characterization 
of these antibodies will aid in the understanding of sperm 
function and fertilization and may provide a useful contra­
ceptive approach.
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CHAPTER 5
EXPERIMENTAL DESIGN AND METHODS 
SPECIFIC AIM NO. 1
Production of murine monoclonal antibodies directed against 
human sperm surface antigens.
a. Sperm surface (coating and integral) antigens extraction 
from human ejaculated sperm and from human testicular 
sperm
Extraction of human ejaculated sperm surface antigens 
Researchers from our laboratory have recently 
investigated and reported (Gupta et al., 1988) a method 
of sperm antigen preparation to optimize production of 
relevant monoclonal antibodies. Human semen ejaculates, 
obtained from normal male donors or from men attending an 
infertility clinic (The Jones Institute for Reproductive 
Medicine, Norfolk), were allowed to liquefy at room tem­
perature. After liquefaction, 0.5 mL of semen was placed 
beneath 2 mL Biggers, Whitten, Whittingham (BWW) medium 
(Biggers et al., 1971) and motile sperm were allowed to 
swim-up for a 90 min incubation period at 37°C. Motile 
sperm in BWW medium were pooled, counted with a Cell Soft
42
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Automated Semen Analyzer (Cryo Resources Ltd, NY), washed 
three times in Tris-buffered saline (TBS) and stored at 
-70°C, (swim-up sperm, Fig. 6). A sperm pool was col­
lected for protein extraction.
Sperm surface antigens were extracted from pools of 
swim-up sperm as follows: the volume of thawed sperm
(500 million sperm) was doubled by addition of 0.6% (0.3% 
final conc.) of NP-40 in TBS (vol/vol), to which 1 mM 
(final conc.) phenyl methyl sulfonyl fluoride (PMSF) was 
added as a protease inhibitor. The suspension was incu­
bated for 1 hour at room temperature with continuous end- 
to-end mixing. After extraction, the suspension was 
centrifuged for 30 minutes at 20,000 g at 4°C. The 
supernatant was collected, pooled, and dialyzed exten­
sively against TBS in a 3,500 molecular weight exclusion 
dialysis membrane at 4°C. Protein concentration was 
measured by a BCA protein assay (Pierce Chemical Company) 
according to manufacturer's suggested protocol insert. 
Briefly, bicinchoninic acid, the key component in the BCA 
protein assay reagent, formed alkali metal salts which 
were soluble in water due to the polar carboxylic acid 
groups. The pyrole reaction product was measured spec- 
trophotometrically at 562 nm. A flow diagram of sperm 
membrane antigen extraction procedure is shown in Fig. 7.
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FIG. 6 Improvement of Semen Parameters by Swim-up
(rise) Technique
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FIG. 7 A Flow Diagram of Sperm Membrane Antigen 
Extraction Process
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Extraction of human testicular sperm antigen
The testicular sperm antigen preparation technique 
developed by Liu et al. (1989) was followed. Briefly, 10 
grams of frozen human testes (obtained from National 
Disease Research Interchange, Philadelphia, PA) was 
homogenized in a glass homogenizer using 20 mL extraction 
buffer containing 50 mM Tris-HCl, 1 mM phenylmethyl 
sulfonylfluoride (PMSF) , pH 8.0 at 4°C. After being 
centrifuged at 27,000 g for 20 minutes at 4°C, the super­
natant was collected. The resulting pellet was resuspen­
ded and centrifuged again. The supernatants were pooled 
and subjected to ammonium sulfate fractionation. Solid 
ammonium sulfate (50 mg/mL) was added to the supernatant. 
This was followed by stirring for 10 minutes. The solu­
tion was centrifuged and the supernatant recovered.
After additional ammonium sulfate (350 mg/mL) was added, 
the supernatant was stirred for 1 hour at 4°C. This was 
followed by centrifugation, after which the pellet was 
dissolved in a minimal amount of 10 mM phosphate buffer 
saline, pH 7.2 (PBS). The solution was dialyzed over­
night against 4 liters of PBS. Protein concentration was 
measured by the BCA Protein assay method (Pierce Chemical 
Company) according to manufacturer1s suggested protocol 
insert.
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b. Immunization of Balb/c mice
i. by conventional immunization method
To generate mouse hybrid cell clones secreting 
monoclonal anti-human sperm antibody, a standard 
technique was used as described elsewhere (Kohler & 
Milstein, 1976). Briefly, Balb/c mice (Jackson Laborato­
ries, Bar Harbor, ME) were immunized subcutaneously (day 
0) with human sperm surface proteins extracted by NP-40 
(50 ug/animal) in complete Freund's Adjuvant, followed by 
an intraperitoneal booster injection in incomplete 
Freund's Adjuvant on day 21 and 28. Mice with the high­
est titer of antisperm antibodies [determined using the 
enzyme-linked immunosorption assay (ELISA)] were given 
intravenous or intraperitoneal injection (100 ug protein 
in TBS) 4 days prior to fusion.
ii. by tolerization of Balb/c mice with common antigenic 
sugar moieties
Tolerogen: A mixture of sugars (galactose + fucose +
mannose + N-acetylglucose) coated on glass beads. 
Immunogen: NP-40 extracted human sperm surface
antigens.
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Tolerization was accomplished by intraperitoneal 
injection of sugar coated beads on weeks 0, 2, and 6. 
After each tolerogen injection, cyclophosphamide at 1 
mg/mL was injected intraperitoneally thrice (10 minutes, 
24 hours and 48 hours after each tolerogen).
Immunization against NP-40 extracted sperm antigens 
was accomplished by intraperitoneal injection, without 
adjuvant, at 7.5 hours and 4 weeks later.
c. Classical hybridoma technique to generate Mabs against 
extracted sperm surface antigens
Immunized spleen cells were fused with mouse myeloma 
cells (either SP2/0 or NS-1) in 3:1 ratio with 50% poly­
ethylene glycol (PEG mol. wt. 1500). After fusion, cells 
were cultured in 96-well plates in selection medium 
containing RPMI-1640 (Gibco Laboratories Inc. Logan, UT), 
and HAT (Hypoxanthine, Aminopterin, Thymidine; Boehringer 
Mannheim, GmbH, West Germany). Ten to fourteen days 
after hybridization supernatant fluids from all wells 
were screened for antisperm antibodies against swim-up 
washed methanol fixed and swim-up washed motile human 
sperm with an ELISA technique. Positive hybridomas were 
expanded and subcloned at least twice under limiting 
dilution culture conditions (0.4 cells/wells). Following 
cloning, large amounts of culture supernatant were pro­
duced in vitro, and ascites fluids containing antibodies
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were produced in vivo by intraperitoneal injection of 3-5 
million hybridoma cells into balb/c mice 10 days after 
priming with 0.5 mL of pristane (2,6,10,14-tetramethyl- 
pentadecane, Sigma Chemical Company, St. Louis, MO). A 
flow diagram for production of anti-sperm MAbs is shown 
in Fig. 8.
d. Determination of class (isotype) and quantitation of 
antibody
Antibody heavy- and light-chain classes were deter­
mined using a mouse immunoglobulin subtype identification 
kit (Zymed Laboratories, South San Francisco, CA). MAb 
concentration in concentrated culture supernatant and 
ascites were quantitated by isotype-specific single 
radial immunodiffusion (Mancini et al., 1965) on stan­
dardized plates (Tago, Burlinghame, CA).
SPECIFIC AIM NO. 2
Localization of antigens reacting with a particular MAb 
restricted to the sperm surface
Immunofluorescence (IF)
To detect any cross reactivity of antisperm monoclonal 
antibodies with human spermatozoa both immunofluorescence 
(IF) (Hjort & Hansen, 1971) and immunochemical staining 
(ICS) were performed. For IF, swim-up human sperm were
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FIG. 8 A Flow Chart for Production of MonoclonalAntibodies
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washed three times by centrifugation with PBS and placed on 
teflon coated spot slides (Roboz, Washington, D.C.) at a 
concentration of 5 million sperm/mL. Slides were air dried, 
fixed for 10 minutes in methanol and frozen at -70°C until 
use. The day that the test was performed, frozen slides 
were thawed at room temperature and washed with PBS and then 
blocked for 30 minutes with 10% normal goat serum, washed 
again with PBS, and then incubated for 60 minutes at room 
temperature or overnight at 4°C with serial dilutions of 
antibody-containing ascites fluids. The slides were then 
washed in PBS, and further incubated for 60 minutes in the 
dark at room temperature with fluorescein isothiocyanate 
(FITC)— conjugated goat anti-mouse immunoglobulins (IgG,
IgA, and IgM; Cappel Laboratory, Cochranville, PA). After 
three to four washings, the slides were mounted in mounting 
media, a coverslip placed over the tissue, and then examined 
under a Zeiss epifluorescence microscope. The principle of 
IF technique is shown in Fig. 9a.
Immunochemical staining (ICS)
ICS technique was performed by using the Zymed Histo- 
stain-sp kit (Zymed Immunohistochemical Kit, Zymed Laborato­
ries, Burlingame, CA). This enzyme immunostain system can 
be used in histochemistry and cytochemistry for localization 
and visualization of antigens as surface markers. The kit 
utilized a biotinylated second antibody, a horseradish
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FIG. 9 A. Principle of Indirect Immunofluorescence (IF)
B. Principle of Immunochemical Staining (ICS)
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peroxidase-streptavidin conjugate and a substrate chromogen 
mixture to demonstrate presence of the antigen in cells or 
tissue. The method of this staining system was as follows: 
Briefly, the methanol fixed human sperm coated spot slides 
were prepared the same way as described in IF technique 
above. Nonspecific background was eliminated by incubating 
sperm with nonimmune serum. The primary antibody to the 
specific antigen was incubated to target antigens. This was 
followed by addition of a biotinylated second antibody which 
served as the linker between the primary antibody and perox­
idase-streptavidin conjugate. The signal generating re­
agent, streptavidin peroxidase was then added to bind to the 
biotin residues on the linking antibody. The presence of 
enzyme was revealed by addition of a mixture of substrate- 
chromogen solution. The enzyme, peroxidase, catalyzes the 
substrate hydrogen peroxide and converts it to chromogen, 
aminoethyl carbazole to a red colored deposit which demon­
strates the location of the antigen. The principle of ICS 
technique is shown in Fig. 9b.
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SPECIFIC AIM NO. 3
Determination of Molecular Weight of the Sperm Antigens by 
Sodium Dodecyl Sulfate Poly Acrylamide Gel Electrophoresis 
(SDS—PAGE) and Western Immunoblotting
To determine the molecular weight of sperm protein 
recognized by antisperm antibodies, the Western 
Immuno-blotting method was performed after SDS-PAG electro­
phoresis of the human sperm NP-40 extract as described by 
Laemmli et al. (1970). Briefly, a discontinuous gel com­
posed of a running gel (10% polyacrylamide; pH 8.8) and a 
stacking gel (3% polyacrylamide? pH 6.8), both with 0.1%
SDS, were made. Samples containing human sperm extract (100 
ug protein) were diluted 1:1 with reducing sample buffer 
(20% glycerol, 3% SDS, 12.5% 0.5M Tris-HCl pH 6.8, 5% 2- 
mercaptoethanol, and 0.5% bromophenol blue) and boiled for 5 
minutes. The electrophoresis buffer chamber contained 25mM 
Tris base, 0.19 M glycine, and 0.1% SDS. Electrophoresis 
was performed at 30 milliamps (constant current) at room 
temperature with a circulating cold water cooling system. 
Known pre-stained standards (BRL, Gaithersburg, MD) consist­
ing of myosin, phosphorylase-B, bovine serum albumin, oval- 
bumin-chymotrypsinogen, B-lactoglobulin, and lysozyme with 
apparent molecular weights of 200, 97, 68, 43, 25, 18, and 
14 KD were also run.
Proteins from the gels were electrophoretically trans­
ferred to a 0.22 uM nitrocellulose membrane (Bio Rad
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Laboratories, Richmond, CA) by the blotting procedure of 
Towbin et al., (1979). In brief, the electrophoretic trans­
fer of proteins was performed at 150 milliamps constant 
current in transfer buffer (25mM Tris, pH 8.4; 192 mM gly­
cine, 20% v/v methanol) overnight at room temperature. Non­
specific binding sites were blocked by incubating the nitro­
cellulose membrane for 2 hours at room temperature with TBS 
containing 0.1% Tween-20 (TBS-Tween) to remove excess BSA 
and were allowed to react with individual monoclonal anti­
body in a miniblotter-45 (Immunetics, Cambridge, MA) for 4 
hours at room temperature. After incubation> the nitrocel­
lulose membrane was washed with TBS-Tween and incubated with 
a 1:300 dilution of peroxidase-labeled rabbit anti-mouse 
immunoglobulins for 1 hour at room temperature. The excess 
conjugate was removed by washing several times with TBS- 
Tween. The enzyme bound to the nitrocellulose was visual­
ized by adding freshly prepared substrate solution (30 mg of 
chloronaphthol (Bio-Rad Laboratories, Richmond, CA) dis­
solved in 10 mL methanol and diluted 1:4 with TBS, to which 
hydrogen peroxide was added at a final concentration of 
0.06%). The reaction was terminated by washing the nitro­
cellulose membrane with distilled water, followed by a 10 
minute incubation and the reaction stopped with a stopping 
solution (0.1% NaN3) . The nitrocellulose blot was washed 
again with distilled water and stored in distilled water 
until photographed.
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SPECIFIC AIM NO. 4.
Determination of reactivity of MAbs with fresh, capacitated, 
and acrosome reacted human sperm
A pool of swim-up human spermatozoa derived from normal 
donors was divided in three groups. The first group was 
washed with PBS (used as fresh sperm), the second group was 
incubated in BWW media 3-5 hours at 37 °C in a humidified 5% 
C02 incubator (used as capacitated sperm), and the third 
group was capacitated for 3-5 hours and then treated with a 
10 uM calcium ionophore A23187 in dimethyl sulfoxide for 30 
minutes (used as acrosome reacted sperm). After treatment, 
sperm were washed three times by centrifugation with PBS and 
reactivity of the MAbs with fresh, capacitated, and acrosome 
reacted human sperm were determined by using ELISA and ICS 
techniques.
Enzyme Linked Immunosorbent Assay (ELISA)
An indirect ELISA with whole sperm was used to screen 
the culture supernatant and ascites fluids for antibody 
activity. Washed human sperm cells (2.5 x 105/well) were 
resuspended in carbonate/bicarbonate buffer, pH 9.6, were 
added to wells of 96-well plates, allowed to settle over­
night at 4°C, and then methanol-fixed and stored at -70°C 
until use.
Frozen coated plates were thawed and washed thrice with 
PBS-Tween buffer to remove methanol and then blocked by 
incubation for 3 0 minute with PBS containing 1% polyvinyl
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alcohol and 0.05% Tween-20 (Sigma) to remove any nonspecific 
binding. Culture supernatant or diluted ascites fluids as 
primary antibodies were reacted overnight at 4°C in wells of 
cell-coated plates. The negative control (NS-1 myeloma cell 
culture supernatant or ascites), a known positive control 
and a blank (reagent buffer) were used with each plate to 
validate the assay. Unbound immunoglobulins were removed 
during three washes with PBS-Tween buffer. Rabbit anti-mouse 
immunoglobulins (IgG, IgA, IgM) conjugated with horseradish 
peroxidase enzyme (Dako Chemical) were used as secondary 
antibody and reacted with bound primary antibodies by incu­
bating 60 minutes at 37°C. After washing thrice with PBS- 
Tween, the bound peroxidase activity was measured by adding 
150 uL/well of orthophenyldinitro (OPD) diluted in 0.1 M 
citrate buffer (pH 4.2, containing 0.03% hydrogen peroxide), 
incubating 10 minutes at room temperature, and stopping the 
reaction by adding 30 uL/well of 4 M sulfuric acid. The 
absorbance was read at 510 nM. The principle of sperm ELISA 
technique is shown in Fig. 10.
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FIG. 10 Principle of Enzyme-linked Immunosorbent
Assay (ELISA)
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SPECIFIC AIM NO. 5
Determining whether these MAbs are against human sperm 
surface antigens
To test whether these MAbs were reactive against sperm 
membrane surface or internal antigens, these MAbs were 
tested by ELISA and IBT (immunobead test) on live sperm.
For ELISA, swim-up washed human spermatozoa were incu­
bated with MAb for 1 hour at 37°C in a humidified 5% C02 
incubator, washed 3-4 times with PBS by centrifugation and 
used to coat the sperm plate for ELISA. Then a regular 
ELISA technique was performed as described previously.
For the indirect immunobead test (IBT), semen from 
normal fertile donors was processed to obtain the motile 
fraction by swim-up technique. The concentration of the 
motile fraction was adjusted to 2 million motile sperm/mL 
and incubated with the MAb for one hour at 37°C and 5% C02 
in air and then excess antibody was removed by centrifuga­
tion. Antibody coated sperm were mixed on a microscope slide 
with rabbit anti-mouse immunoglobulins (IgG and IgM; Zymed, 
San Francisco, CA) and the mouse Ig coated beads (polyacryl­
amide beads conjugated with highly purified anti-mouse 
antibodies of IgG and IgM class) and the motile sperm were 
examined for number and location of beads attached.
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SPECIFIC AIM NO. 6
Evaluation of sperm specificity by cross-reactivity studies 
of the newly generated panel of Mabs
Washed human sperm cells (2.5 x 105/well) , red blood
cells (2.0 x 105/well), Raji cells (1.5 x 105/well), lympho­
cytes (1.5 x 105/well) , and bacteria (5 x 105/well) were
resuspended in carbonate/bicarbonate buffer, pH 9.6, were 
then added to wells of 96-well plates, allowed to settle 
overnight at 4°C, and then methanol-fixed and stored at 
-70°C until use. To test any cross reactivity of antisperm 
MAbs with these cells, regular ELISA was performed as 
described previously.
SPECIFIC AIM NO. 7
Localize the origin of sperm antigens in the reproductive 
system reacting with a particular MAb
To detect any cross-reactivity of antisperm monoclonal 
antibodies with human reproductive tissue sections (pros­
tate, epididymis, vas, seminal vesicle, testes), both 
immunofluorescence (IF) (Hjort & Hansen, 1971) and immuno­
chemical staining (ICS) were performed. For IF, methanol 
fixed frozen human reproductive tissue sections (available 
in our laboratory stored at -70°C.) were washed in PBS and 
then blocked for 30 minutes with 10% normal goat serum, 
washed again with PBS, and then incubated for 60 minutes at 
room temperature or overnight at 4°C with serial dilutions
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of antibody-containing ascites fluid. The slides were then 
washed in PBS, and further incubated for 60 minutes in the 
dark at room temperature with fluorescein isothiocyanate 
(FITC)- conjugated goat anti-mouse immunoglobulins (IgG,
IgA, and IgM; Cappel Laboratory, Cochranville, PA). After 
three to four washings, the slides were mounted in mounting 
media, a coverslip was placed over the tissue, and then the 
slides were examined under a Zeiss epifluorescence micro­
scope.
ICS technique was performed by using the Zymed Histo- 
stain-sp kit (Zymed Immunohistochemical Kit, Zymed Laborato­
ries, Burlingame, CA) as described previously.
SPECIFIC AIM 8
Localization of antigens reacting with particular Mabs 
restricted to human and other mammalian sperm surfaces
To detect whether or not these anti-human sperm antibod­
ies cross-react with other animal sperm, methanol-fixed 
sperm (dog, mouse, rat, rabbit, monkey, hamster, bull, 
baboon etc.) smears on spot slides were tested according the 
sperm immunofluorescence (IF)/or immunochemical staining 
(ICS) procedures as described previously.
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SPECIFIC AIM NO 9
Determine whether these antisperm antibodies have functional 
significance
To evaluate whether antisperm antibodies to these anti­
gens have any functional significance, sperm immobilization 
tests, sperm agglutination tests, cervical mucus penetration 
tests, hamster egg penetration tests, and hemizona tests 
were done.
a. Sperm Immobilization assay
Monoclonal antibodies were evaluated for their abili­
ty to agglutinate and immobilize sperm with a modifica­
tion of the methods described by Rose (Rose et al., 1976) 
and the Isojima sperm immobilization test (Isojima et 
al., 1968) respectively. The agglutination and immobili­
zation assays were run concomitantly. For the immobili­
zation test, swim-up washed human sperms were collected 
and resuspended to 40 million motile sperm/mL in BWW 
buffer pH 7.5. An aliquot of normal guinea pig sera 
(Cappel, Worthington, PA) was heat inactivated at 56°C 
for 30 minutes to remove complement activity and the 
assay was carried out in flexible flat bottom 96-well 
plates. Serial doubling dilutions of monoclonal antibod­
ies were prepared for the immobilization assay by deliv­
ering 20 uL normal guinea pig sera to 6 wells in the 96- 
well tray and a parallel number of wells received 20 uL
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of heat inactivated guinea pig sera. Into the first well 
of each series were delivered 20 uL monoclonal antibodies 
and 20 uL was propagated through the next 5 wells to give 
a 1:2 through 1:64 dilution series. Two uL of sperm were 
injected into each well and then all wells were covered 
with 2 drops of liquid paraffin oil and placed in a 37°C 
incubation chamber for 30 minutes. A proven positive and 
negative control ascites or serum diluted in saline were 
used to validate each assay. The sperm immobilization 
was determined by using a normal light microscope and 
immobilization values were recorded at which titer there 
were 0-5% mobilization. Fig. 11 illustrates the princi­
ple of complement-dependent sperm cell lysis (immobiliza­
tion) .
b. Sperm agglutination assay
The sperm agglutination test was run employing a 
similar scheme and similar materials. In a 96-well 
microtiter plate 12 series spots were prepared by adding 
36 uL BWW to the first well and 20 uL BWW to all subse­
quent wells. Four uL of monoclonal antibodies were then 
delivered to the first well and after mixing, 20 uL of 
this mixture were propagated through the next 11 wells to 
give a 1/10 doubling dilution series. Two uL of sperm 
were delivered to each well followed by an overlay of two 
drops of liquid paraffin oil and incubated 2 hours at
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FIG. 11 Principle of Complement-dependent Sperm 
Cell Lysis (Sperm Immobilization Assay)
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37°C. Titer of 1:20 or higher giving agglutination was 
considered positive. Microscopic examination of the 
sperm also provided the information on the location of 
the antibody binding on the surface, eg on the head, 
tail, midpiece, or tail tip. The Fig. 12 illustrates 
some common sperm agglutination patterns.
c. Cervical Mucus Penetration Test
The procedure as described by Serono Diagnostics for 
the cervical mucus penetration assay (PENETRAK) was 
modified for the assessment of antibody interaction. 
Briefly, sperm (60 x 106/ml) were treated for one hour 
at 37°C in a humidified 5% C02 incubator with optimal 
antibody titer (in the case of agglutinating antibodies 
the same or one titer step beyond the agglutination titer 
of the antibody was used). Then the normal protocol for 
cervical mucus penetration was performed according to the 
manufacturer's directions (Serono Diagnostics, Braintree, 
MA) .
d. Hamster Egg Penetration Assay (SPA)
The hamster egg penetration assay was used as an in 
vitro method for assessment of the sperm ability to 
undergo capacitation and the acrosome reaction, and to, 
subsequently bind and penetrate the oocyte plasma mem­
brane and then to undergo decondensation within the
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oocyte. The SPA technique was originally reported by 
Yanagimachi et al. (1976). Our laboratory has modified 
the procedure to test for the ability of antisperm 
antibodies to affect capacitation events as well as to 
post capacitation events. In brief, human sperm were 
incuba-ted with monoclonal antibodies during or after 
their capacitation period. All agglutinating MAbs were 
papain digested to collect the Fab fragments according to 
manufacturer's guidelines (Pierce, Rockford, IL) . The 
medium used for handling sperm and oocyte prior to insem­
ination was N-2-hydroxyethylpiperazine-N'-2-ethane- 
sulfonic-acid-buffered Biggers, Whitten, Whittingham 
(BWW) medium supplemented with BSA (Sigma Chemical Compa­
ny, St. Louis, MO); penicillin; and streptomycin. Oocyt­
es were obtained from mature hamsters given intraperito- 
neal injections of 40 IU of pregnant mare serum (Gestyl, 
Organon, Holland) 2 hours after initiation of the light 
phase of a 14:10 H light:dark cycle on the day of estrus 
(day of ovulation). Fifty-six hours later, the hamsters 
were injected IP with 40 IU of human chronic gonadotro­
phin hCG, (Sigma Chemical Company, St. Louis, MO). On 
the same day a fresh semen sample was collected and 
allowed to liquify at 37°C for 30 minutes. A one-half 
milliliter aliquot of semen under 1 mL BWW was distribut­
ed into 15 mL conical centrifuge tubes and incubated for 
60-90 minutes at 37°C (swim-up procedure) . The BWW
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fractions were removed and evaluated for sperm motility 
and grade of progression. A sperm count was performed 
and the concentration of the mixture was adjusted to 10 
million sperm with BWW media. Sperm were incubated 
overnight in 5% C02 and humid air at 37°C as the conical 
centrifuge tube was resting at a 30-40° angle.
Oocytes from superovulated hamsters were then col­
lected from the oviducts 15-16 hours after the hCG injec­
tion. The surrounding cumulus cells were removed by 
treatment of the eggs with 0.1% hyaluronidase (Sigma 
Chemical Company, St. Louis, MO) in BWW medium. The zona 
pellucida were removed by treatment with 0 .1% trypsin in 
BWW media (twice crystallized; Sigma Chemical Company,
St. Louis, MO). The zona-free oocytes were then passed 
through five BWW washes to remove enzymes.
Concomitant with the egg processing, the sperm sam­
ples were evaluated and adjusted to 3.3 million motile 
sperm/mL of BWW media. A 100 ul drop of sperm was placed 
in a sterile plastic petri dish and covered with paraffin 
oil; 20-3 0 oocytes in 50 uL were deposited in the sperm 
drop (for a final concentration of 2.5 million motile 
sperm/mL) and incubated at 37°C in 5% C02 in humid air 
for 3 hours. Oocytes were evaluated for penetration 
after transfer of the eggs into fresh BWW medium to wash 
excess sperm from the egg and then placement of 10 eggs 
onto a slide (approximately 50 uL drop) and compression
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of the eggs under a 22 x 22 cm coverslip. Penetration 
was evaluated by phase-contrast microscope at 400X. An 
egg was considered fertilized when it contained at least 
one swollen sperm head with an accompanying sperm tail.
e. Hemizona Test (HZA)
The hemizona assay (HZA) has been used as a clinical 
tool to evaluate patients and predict fertilizing poten­
tial. Overstreet et al. (1976) first suggested the use 
of zona intact nonliving human oocyte to examine the 
sperm-zona pellucida binding. Researchers at our Insti­
tute have further modified this technique by taking the 
nonliving oocytes, cutting them in half by micromanipula­
tion, removing the ooplasm and the two zona pellucida 
almost identical halves called the "hemizona". These 
halves are identical and therefore one half can provide 
an excellent internal control for the examination of 
various aspects of sperm-zona pellucida binding, a neces­
sary prerequisite for human fertilization. Our purpose 
is to see whether the developed antisperm monoclonal 
antibodies could block the sperm-zona attachment, and 
thus prevent possible fertilization.
The procedure, as it is used for clinical testing, 
has been described in detail elsewhere (Franken et al. 
1989). Briefly, human oocytes were obtained from cadaver 
tissues or surgically excised ovarian tissue. The
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oocytes were stored until use at 4°C in a solution of 1.5 
M magnesium chloride with 0.1% polyvinyl pyrolidone (PVP, 
MW 36,00) and 40 mM HEPES buffer to stabilize the pH at 
7.0. One day prior to use, the salt stored oocytes were 
rinsed copiously in BWW supplemented with 0.35% BSA. The 
oocytes were cut in half using Narishige micromanipulator 
(Narishige, Tokyo, Japan) mounted on a phase-contrast 
microscope (Nikon Diaphot, Garden City, NY). The ooplasm 
was removed by pipetting each hemizona through a finely 
pulled pipette. Each pair of hemizona was stored over­
night in a droplet of medium under mineral oil. The 
following day, the hemizona were rinsed in Ham's F-10 
supplemented with human fetal cord serum and incubated at 
37°C and 5% C02 in air. Semen specimens obtained from 
healthy proven fertile donors, were overlayed with medium 
to allow the sperm to swim-up into media. The motile 
fraction was collected and adjusted to a concentration of 
0.5 million sperm/mL. One of the pair of hemizona was 
added to a control drop of sperm, while the other was 
added to the experimental drop (swim-up motile sperm 
incubated with specific monoclonal antibodies). After 
incubation, each hemizona was rinsed in fresh medium to 
dislodge loosely attached sperm, and the number of sperm 
tightly bound to the surface of the zona pellucida was 
counted. A flow diagram of the hemizona assay is shown 
in Fig. 13.
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FIG. 13 The Hemizona Assay (HZA) Flow Diagram
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Collect Swim-up Washed Human Spermatozoa from Fertile Donors 
(Adjust 0.5 million sperm/mL of Ham's F10 medium))
1TEST
Expose Sperm to MAb (1:10)
CONTROL 
Expose Sperm to NS-1 (1:10)1Prepare Sperm Drop Under 
Oil (0.5 million/mL)
I
Prepare Sperm Drop Under 
Oil (0.5 million/mL)
i
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i i
After Coincubation of 4 hours, Rinse Each Hemizona 5x to
Dislodge Loose Sperm.
1
Count Sperm Bound to Outer Surface of Zona
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SPECIFIC AIM NO. 10
Determine whether a carbohydrate moiety on the sperm surface 
may be involved in antigen.
  ««r _ j ___• a _ jl_ _ T?TTOAaodium ntsi-ci- ftsx. luuauc ucaucu ô /cxiu û xua
To determine whether destruction of the carbohydrate 
moieties on sperm surface could affect antibody binding, 
human sperm aliquots were first treated with 0.5%, 1.0%, and 
2 .0% sodium meta-periodate solution and then the regular 
ELISA technique was performed as described previously. With 
each monoclonal antibody a control assay (untreated sperm 
ELISA) was also done to compare the percent of inhibition.
SPECIFIC AIM NO. 11
Determine whether a reduction in fertility occur in mice 
in vivo.
Passive Immunization of Mice With Monoclonal Antibodies 
The purpose of this experiment was to determine the 
effects of passive immunization with monoclonal antisperm 
antibodies on mouse fertilization in vivo. The experimental 
method was followed according to the protocol described by 
Saling et al. (1985c). Briefly, female mice 5-8 weeks of 
age were superovulated by the standard protocol. At the 
time both the PMSG and hCG injections were given, each
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female was given an additional IP injection of 0.5 mL 
monoclonal antibody. Following the hCG injection, the 
females were housed with a male (2 females and 1 
male/cage). The following morning each female was checked 
for vaginal plugs. Only those females with vaginal plugs 
were considered in the subsequent experiments. Females were 
sacrificed 40-44 hours post-hCG injection and their oviducts 
were excised. Normal fertilization was assumed to have 
occurred when embryos (two cells or later stage) were recov­
ered. The number of embryos and the number of uncleaved 
(one cell) oocytes were recorded. Four different doses of 
antibody were used (0.4, 1.0, 2.0, 4.0, mg/0.5 mL). The 
number of mice at each dose were 6 females and 3 males; so 
each test series involved 24 females and 12 males.
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CHAPTER 6
RESULTS
A total of five hybridizations were done by fusing 
SP/O-Agl.4 or NS-1 mouse myeloma cells with splenocytes from 
mice immunized with human sperm membrane antigens. Two 
extraction techniques were used for sperm membrane antigen 
isolation. In the first technique NP-40 detergent was used 
for antigen extraction from a pool of swim-up washed human 
spermatozoa collected from several donors. In the second 
technique mechanical homogenization of human testis was used 
for antigen extraction.
Among the 130 hybrid cell clones secreting monoclonal 
antisperm antibodies that were produced, 15 clones, based on 
their sperm specificity, antibody titers, antibody class, 
site of antigen recognition on the sperm surface, and the 
molecular weight of their binding antigens, were selected 
for further characterization. These hybridoma cell lines 
along with their antibody class (isotype) are given in 
Table 1. Eight out of fifteen were of the immunoglobulin 
(Ig) M and seven were IgG class. Among the seven IgG mono- 
clonals; three were IgGi, three were IgG3, and one was IgGzb.
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TABLE 1 PROPERTIES OF FIFTEEN MONOCLONAL ANTIBODIES RAISED 
AGAINST HUMAN SPERM SURFACE ANTIGENS
Mabs Ag prep Ab Class Ag location Mol Wt. KD
DH3 NP-40 IgM T,N, Ac Sup. 68,25,14+/-
DH4 NP-40 IgM T, N, PA Sup. 65,25
DH13 NP-40 IgM T, PA Sup. > 2 0 0
DH14 NP-40 IgM T, N, PA Sup. -
DH21 NP-40 IgM N,PA,Eq Asc. 68,45,37,23,14
DH22 NP-40 IgM PA,T,N,Eq(+/-)
*[Ac,PA,T(+/-))
Asc. 68,14+/-
DH113 NP-40 IgG2b Eq,N,PA Sup. 65,50,14
DHF5 NP-40 Igc3 T, PA sup. 65,50
DH200 NP-40 IgG3 WS Sup. -
DH201 NP-40 IgGi T, PA Sup. 14
DH202 NP-40 IgGi H Sup. 14
DH203 NP-40 IgG3 Ac,T Asc. -
DH205 NP-40 IgG, H(rim),Eq,T Sup. 14,20-25
DHTB11 Testicular
extract
IgM N, PA Sup. 65
DHTol
P3C9
NP-40 IgM N, PA Sup. 6 8 , 65
T(tail), Ac(acrosome), N(neck), PA(postacrosome) , H(head), WS(whol 
sperm), Eq(equatorial), Sup(culture supernatant), Asc(ascities) 
Mabs(monoclonal antibodies)
* on acrosome reacted sperm
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Antigen localization
The locations of antigens recognized by the Mabs were 
examined using immunofluorescence (IF) and immunochemical 
staining (ICS) of methanol-fixed sperm from humans (Table 
1). The fifteen antibodies all showed staining when biotin- 
avidin ICS and IF staining procedures were employed. These 
monoclonals often appeared to bind to multiple sites on 
human sperm. DH3 reacted with tail, neck, and acrosome 
regions; DH200 reacted with whole sperm; DH201 with tail and 
post-acrosome; whereas DH202 reacted with the entire head 
region of sperm. Among the others, DH4 and DH14 reacted 
with the tail, neck, and post-acrosome; DH13, DH201, and 
DHF5 with the tail and post-acrosome; DH21 with the neck, 
post-acrosome and equatorial region; DH22 with the post- 
acrosome, tail, neck, and equatorial (some) of non-acrosome 
reacted sperm and acrosome, post-acrosome, and tail (+/-) of 
acrosome reacted sperm; DH113 with the equatorial, neck, and 
post-acrosome; DH203 with the acrosome and tail; DH205 with 
the head rim, equatorial and tail; DHTBn and DHT0IP3C9 with 
the neck and post-acrosome region of human spermatozoa.
Some of these MAb binding patterns with human sperms are 
shown in Fig. I4(a-g).
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F I G . 1 4
a. Antisperm MAb DH14 bound to postacrosome, 
neck and tail of human sperm (by IF).
b. Antisperm MAb DH22 bound to acrosome, post 
acrosome, and tail (+/-) of acrosome-reacted 
human sperm (by IF).
c. Antisperm MAb DH22 bound to postacrosome, 
equatorial (+/-), neck, and tail of fresh 
(not acrosome-reacted) human sperm (by IF).
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b. c.
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FIG. 14
d. Antisperm MAb DH13 bound to postacrosome and 
tail of human sperm (by ICS).
e. Antisperm MAb DHTBn bound to postacrosome 
and neck of human sperm (by ICS).
f. Antisperm MAb DH202 bound to the entire head 
of human sperm (by ICS).
g. Antisperm MAb DH200 bound to all regions of 
human sperm (by ICS).
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f. g.
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Molecular Weight of Corresponding Antigens
These monoclonal antibodies revealed multiple bands 
by immunoblotting procedures. DH3 and DH4 recognized anti­
gens having apparent molecular weights of 68 and 25 KD. In 
addition to the 68 and 25 KD bands, DH3 also recognized a 14 
KD region. DH13 recognized antigens with a 273 KD, and DH21 
recognized 6 8 , 45, 37, 23, and 14 KD bands. DH 22 recog­
nized two bands, 68 and 14 KD, DH 113 recognized three bands 
of 65, 50, and 14 KD, DHF5 and DH201 each recognized one 
band of 14 KD, and DH205 recognized two bands of 2 0 and 14 
KD. Immunoblot of antisperm MAbs binding to sperm protein 
extract is shown in Fig. 15.
Reactivity of the Monoclonals with Fresh, Capacitated, and 
Acrosome Reacted Human Sperm by ELISA and ICS
Reactivity of the monoclonals with fresh, capacitated, 
and calcium ionophore treated (acrosome reacted) human sperm 
was evaluated by ELISA and ICS. The results are shown in 
Table 2. One monoclonal, DH22, showed higher reactivity 
with acrosome reacted spermatozoa than to fresh and capaci­
tated human spermatozoa. All others showed higher reactivi­
ty with fresh and capacitated spermatozoa in contrast to 
acrosome reacted human spermatozoa.
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FIG. 15
Immunoblot of antisperm MAbs binding to NP-40 extract
proteins of human sperm. Sperm extract was electropho-
resed under reduced conditions.
Lane 1 Known molecular weight markers of lysosome,
14KD; beta lactoglobin, 18KD? alpha chymotryp- 
sinogen, 25KD? ovalbumin, 43KD; bovine serum 
albumin, 6 8KD; phosphorylase b, 97KD; and 
myosin 200KD.
Lane 2 Antisperm MAb DH3 recognized 6 8 , 25, and 14 
KD.
Lane 3 Antisperm MAb DH4 recognized 65 and 25 KD.
Lane 4 Antisperm MAb DH13 recognized >200 KD.
Lane 5 Antisperm MAb DH14 did not recognized any 
protein band.
Lane 6 Antisperm MAb DH21 recognized 6 8 , 45, 37, 23, 
and 14 KD.
Lane 7 Antisperm MAb DH22 recognized 68 and 14 KD.
Lane 8 Antisperm MAb DH113 recognized 65, 50, and 14 
KD.
Lane 9 Antisperm MAb DHF5 recognized 65 and 50 KD.
Lane 10 Antisperm MAb DH200 did not recognized any 
protein band.
Lane 11 Antisperm MAb DH201 recognized 14 KD.
Lane 12 Antisperm MAb DH202 recognized 14 KD.
Lane 13 Antisperm MAb DH203 did not recognized any 
protein band.
Lane 14 Antisperm MAb DH205 recognized 14 and 20-25 
KD.
Lane 15 Antisperm MAb DHTB11 recognized 65 KD.
Lane 16 Antisperm MAb DHTolP3C9 recognized 68 and 65 
KD.
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TABLE 2 REACTIVITY OF MONOCLONAL ANTIBODIES WITH FRESH,








DH3 ++/ T,N,Ac ++/ Eq,T +/ T*,Eq*
DH4 ++/ T,N,PA ++/ T,N +/ T*,N*
DH13 ++/ T,PA ++/ WS +/ T*,Eq*
DH14 ++/ T, PA ++/ WS +/ WS*
DH21 ++/ Eq,PA,N ++/ +DH22 ++/ PA,T,N,Eq ++/PA,T,N,Eq +++/ Ac,PA,T,N,
DH113 ++/ Eq,PA,N ++ +/DHF5 ++/ T,PA ++/ T,PA +/ -DH200 ++/ WS ++/ N,Eq +/ "DH201 ++/ T,PA ++/ WS +/ -DH202 ++/ H ++/ +/DH203 ++/ Ac,T ++/ H +/T,H*
DH205 ++/ H,T ++/ Eq,T +/-DHTB11 ++/ PA,N ++/ Eq,T +/DHTolP3C9 ++/ PA,N ++/ +/
+ optical density 2-3 times above background 
++ optical density 8 - 1 0 times above background 
+++ optical density > 1 0 times above background
Fresh swim-up washed human sperm coated on spot slide and air 
dried
Capacitated swim-up sperm with BWW media incubated overnight at 
37°C, 5% C02 then washed and coated on spot slide and air dried. 
Acrosome-reacted swim-up sperm with BWW media and calcium 
ionophore are incubated overnight at 37°C, 5% C02 then washed and 
coated on spot slide and air dried.
ELISA Enzyme Linked Immuno Sorbant Assay 
ICS Immunocytochemical Staining 
* Faint staining
Ac(acrosome), Eq(equatorial), H(head), N(neck), PA(postacrosome), 
T(tail), WS(whole sperm)
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Studies on Surface vs Internal Antigens
To test whether these Mabs are reactive against the 
sperm membrane surface or internal antigens, we tested them 
with a live sperm ELISA and with immunobead assays 
(Table 3 ). All of the fifteen MAbs showed positive binding 
with live sperm. Selecting antibodies which reacted only to 
surface antigens was one of the goals of our study.
Specificities of Monoclonal Antisperm Antibodies
Sperm specificity of these monoclonal antibodies was 
investigated by ELISA with white blood cells (WBC), red 
blood cells (RBC), lymphoblastoma (LBO) cell line, bacteria, 
human seminal plasma, human albumin, and human lactoferrin. 
As shown in Table 4, none of these monoclonals reacted with 
either WBC, RBC, LBO, bacteria, human albumin, or human 
lactoferrin. DH 200-203 slightly and DH205 moderately 
reacted with seminal plasma.
Cross reactivity of these monoclonals with various 
frozen human somatic tissue sections (myometrium, adrenal, 
thyroid, liver, lungs) was investigated by immunofluores­
cence and immunochemical staining. Results are shown in 
Table 4. None of these monoclonals reacted with any of 
these human somatic tissue sections tested.
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TABLE 3 STUDIES ON SURFACE VS INTERNAL ANTIGENS
MAbs Live sperm ELISA Immunobead Test (IBT)
DH3 ++ N, T
DH4 ++ N,T
DH13 ++ H, T
DH14 ++ H, T
DH21 ++ H, N
DH22 ++ H, T
DH113 ++ H, N
dhf5 ++ H, T
DH200 ++ H, T
DH201 ++ T
DH202 ++ H
DH203 ++ H, T
DH205 ++ H, T
DHTBn ++ H,N
DHT0IP3C9 ++ H,N
++ 8 - 1 0 times above background
H (head), N (neck), T (tail)
ELISA (enzyme-linked immunosorbant assay) 
MAbs (monoclonal antibodies)
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TABLE 4 SPECIFICITY OF ANTISPERM MONOCLONAL ANTIBODIES




DH3 - - * - * - - — -
DH4 - - * - * - - - -
DH13 - - * - * - - - -
DH14 - - * - * - - - -
DH21 - - * - * - - - -
DH22 - - * - * - - - -
DH113 - - * - * - - - -
DHF5 - - * - * - - - -
DH200 - - - ** - +/- - -
DH201 - - -  ** - +/- - -
DH202 - - - ** - +/- - -
DH203 - - - ** - +/- - -
DH205 - - - ** - + - -
DHTB11 - -  * -  ** - - - -
DHTol
P3C9
— -  * -  ** - - - -
hybridoma supernatant tested as 1 : 1 0 0 dilution
** hybridoma supernatant tested as 1:50 dilution (all other 
tests were done as neet by using hybridoma supernatant)
+/- when ELISA optical density twice than negative control 
WBC (white blood cell), RBC (red blood cell),
LBO (lymphocyte), Bact (bacteria staphylococci, streptococci, 
salmonella, klebsiella), lact. (lactoferrin), Alb. (human 
albumin)
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Localization of Antigenic Epitopes Corresponding to MAbs in 
Reproductive System
To determine the possible origination of the antigenic 
epitopes corresponding to these MAbs in the reproductive 
system, immunofluorescence and immunochemical staining 
techniques were used for staining human frozen testes, 
epididymis (caput, corpus, cauda) vas, seminal vesicle, and 
prostate tissue sections (Table 5). DH3, DH113, DH200-203, 
and DHTBn bound to spermatozoa and spermatid in the testis; 
DH4, DH14, and DH205 bound to epithelium of the seminal 
vesicle; DH13, DH21, DH22 and DHF5 bound to glandular 
epithelium of the cauda and sperm in the cauda; and DHTol- 
P3C9 bound to sperm in the testes, the epididymis (caput, 
corpus, and cauda), and the vas defferens. Some of these 
MAbs binding patterns on different tissue sections are shown 
in Fig. 16 (a-h).
Cross-Reactivity of Monoclonal Antibodies With Other 
Species' Spermatozoa
Reactivity of these antisperm monoclonal antibodies with 
other species' spermatozoa (monkey, dog, rabbit, mouse, rat, 
and bull) was done by immunochemical staining and immunoflu­
orescence study (results are shown in Table 6 ). Most of 
these monoclonal antibodies showed reactivity with sperm of 
several species; DH 3 reacted with all species tested except 
monkey sperm; DH4 with dog and bull sperm; DH13 reacted with
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TABLE 5CROSS REACTIVITY STUDY AGAINST HUMAN TISSSUES OF ANTI­
HUMAN SPERM MONOCLONAL ANTIBODIES BY 
IMMUNOFLUORESCENCE STUDY
MAbs Prost Myomet Adren Thyroid Liver Lungs Testes Caput Cauda Vas sem
DH3 - - - - - - + - - - -
DH4 - - - - - - - - - - +
D H 13 - - - - - - - - + - -
D H 14 - - - - - - - - - - +
D H 21 - - - - - - - - + - -
D H 22 - - - - - - - - + - -
D H 1 1 3 - - - - - - + - - - -
D H F5 - - - - - - - + + - -
D H 2 0 0 - - - - - - + - - - -
D H 2 0 1 - - - - - - + - - - -
D H 2 0 2 - - - - - - + - - - -
D H 2 0 3 - - - - - - + - - - -
D H 2 0 5 - - - - - - - - - - +
D H T B 11 - - - - - - + - - - -
TolP3C9 - — - - - - + + + + -
prost(prostate gland), myomet(myometrium), adren(adrenal 
gland), sem(seminal vesicle)
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FIG. 16
a. Antisperm MAb DHF5 bound to caudal region of 
human epididymis (by IF) .
b. Antisperm MAb DH13 bound to caput region of 
human epididymis (by IF) .
c. Antisperm MAb DHP3C9 bound to caput region 
of human epididymis (by IF).
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FIG. 16
d. Antisperm MAb DH4 bound to human seminal 
vesicle components (by IF).
e. Antisperm MAb DH14 bound to human seminal 
vesicle components (by IF) .
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FIG. 16
f. Antisperm MAb DH3 bound to human testis 
components (by IF).
g. Antisperm MAb DHT0 IP3C9 bound to human 
testis components (by IF).
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FIG. 16
h. Antisperm MAb DHTBn bound to human testicu­
lar spermatozoa and spermatids (by IF) .
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TABLE 6 REACTIVITY OF ANTI-HUMAN SPERM MONOCLONAL 
ANTIBODIES WITH DIFFERENT SPECIES SPERM BY 
IMMUNOCHEMICAL STAINING (ICS) STUDY
MAbs Monkey Dog Rabbit Mouse Rat Bull
DH3 - Ac, N AC Ac,T WS Ac
DH4 - AC - - - Ac
DH13 Ac,T Ac, T Ac,T Ac, T ND Ac
DH14 - Ac Ac+/— - - Ac
DH21 - Ac - - - Ac
DH22 Ac,Eq,T - ND Ac,N ND Ac
DH113 ND Ac ND ND ND Ac
DHF5 - ND Ac T Mp Ac
DH200 - - - T ND Ac
DH201 Ac Ac Ac Ac ND Ac
DH202 Eq,T - Ac,N,Mp H - Ac
DH203 Ac - Ac H - Ac,T
DH205 - Eq ND - - ND
DHTBn - Ac,Eq Ac, N T Mp Ac, N




Ac(Acrosome), Eq(equatorial), N(neck), T(tail), 
Mp(midpiece), H(head), ND(notdone)
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all species' sperm; DH14 reacted with dog, rabbit, and bull 
sperm; DH21 reacted with dog and bull sperm. DH22 reacted 
with all except dog sperm; DH113 and DHF5 reacted with 
rabbit, mouse, rat, and bull sperm; DH200 with mouse and 
bull sperm; DH201 reacted with all species' sperm; DH202 and 
DH203 reacted with all except dog and rat sperm; DH 205 
reacted with dog and bull sperm; and DHT0IP3C9 reacted with 
monkey, dog, mouse, rat, and bull sperm. Some of these MAbs 
binding patterns with different species' sperm are shown in 
Fig. 17 (a-k).
Sperm Agglutination And Immobilization Assay
To see whether any inhibition of sperm functional tests 
(SA/SI) can occur by these monoclonal antibodies, micro 
sperm agglutination and immobilization assays were done 
(data shown in Table 7a). Among fifteen monoclonal antibod­
ies; DH200, DH201, DH202, and DH203 caused agglutination and 
DH200, DH202, and DH203 immobilized human spermatozoa in the 
presence of complement. Furthermore, these same four mono- 
clonals caused agglutination and immobilization of mouse 
spermatozoa (Table 7b). The pattern of agglutination was 
chain with DH200, cluster with DH201 and DH202, and mixed 
with DH203.
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FIG. 17
a. Antisperm MAb DHT0IP3C9 bound to acrosome 
and xnidpiece of bull sperm (by ICS) .
b. Antisperm MAb DH3 bound to acrosome of bull 
sperm (by ICS).
c. Antisperm MAb DH13 bound to acrosome of bull
sperm (by ICS) .
d. Antisperm MAb DHTBn bound to acrosome and
neck of rabbit sperm (by ICS).
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FIG. 17
e. Antisperm MAb DHTBn bound to midpiece of 
rat sperm (by ICS).
f. Antisperm MAb DH3 bound to all regions of
rat sperm (by ICS).
g. Antisperm MAb DH3 bound to acrosome and tail
of mouse sperm (by ICS).
h. Antisperm MAb DHT0 IP3C9 bound to acrosome 
and midpiece of mouse sperm (by ICS).
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FIG. 17
i. Antisperm MAb DH3 bound to acrosome and neck 
of dog sperm (by ICS).
j . Antisperm MAb DH202 bound to acrosome, neck, 
and midpiece of rabbit sperm (by ICS).
k. Antisperm MAb DH203 bound to acrosome of 
monkey sperm (by IF).
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TABLE 7a
REACTIVITY OF MONOCLONAL ANTI-HUMAN SPERM ANTIBODIES IN 











DH200 >64 >20480 (chain)
DH201 - >20480 (cluster)
DH202 16 >20480 (cluster)





REACTIVITY OF MONOCLONAL 
SPERM IMMOBILIZATION AND 
MOUSE SPERM
ANTI-HUMAN SPERM ANTIBODIES IN 









DH203 >64 >20480DHTBn - -
DHT0 IP3C9 “ —
- (negative), 64 (at 1:64 dilution), 20480 (at 1:20480 
dilution)
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Hamster Egg Penetration Assay
The ability of these antisperm monoclonal antibodies to 
prevent human spermatozoa to penetrate zona free hamster 
oocyte was investigated and results are given in Table 8 . 
Among these fifteen monoclonals, DH3, DH13, DH14, DH22, 
DH205, and DHTo1P3C9i significantly inhibited hamster egg 
penetration. Only DH3 and DH13 inhibited human sperm pene­
tration of zona free hamster eggs when treated with pre­
capacitated sperm but not post-capacitated sperm. On the 
other hand, MAb DH22 showed stronger inhibition when incu­
bated with post-capacitated sperm.
Hemizona Assay
The hemizona assay (sperm functional test) was done with 
MAbs to evaluate inhibition of sperm egg attachment due to 
binding of these antibodies. Two to four hemizona were 
assessed for each MAb. These MAbs were also sent to another 
laboratory (Jane Rogers, Vanderbilt University, TN) to 
repeat the assay and to confirm the test results. A hemi­
zona index (HZI) calculated by counting the number of tight­
ly bound sperm on the test zona and dividing by the number 
of tightly bound sperm on control zona. This number was 
multiplied by 100 to obtain the percentage. A HZI of less 
than 50% was considered to represent significant inhibition 
of sperm egg attachment probably due to the presence of 
antisperm antibodies. Of the 15 MAbs tested, 7 inhibited
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TABLE 8 ZONA FREE HAMSTER EGG PENETRATION ASSAY**
(SPA)
Normal Donor DH3 DH4 NS-1
SPA 100% 34%, *92% 78%,*88% 100%
PI 4.5 0.55, 3.5 1.6, 5.2 6.6
%lnhib. 0% 66% 8% 22%,*12% 0%
Normal Donor DH13 DH14 NS-1
SPA 92% 30%, *90% 32%,*25% 100%
PI 3.6 0.4, 2.5 1.25 4.5
%Inhib. 8% 70%, *10% 68%,*75% 0%
Normal Donor DH22 dhf5 NS-1
SPA 100% 56% *25% 66% 93%
PI 3.0 0.87 0.83 3.5
%Inhib. 0% 44%,*75% 34% 7%
Normal Donor DHT0IP3C9 DH201 NS-1
SPA 100% 42% 71% 86%PI 3.0 0.5 1.1%Inhib. 0% 56% 29% 14%
Normal Donor DH21 DH205 NS-1
SPA 95% 54% 59% 96%PI 3.3 0.75 0.95 3.8%Inhib. 5% 46% 41% 4%
Normal Donor DH203 DH113 NS-1SPA 100% 75% 70% 93%PI% 5.7 1.2 0.95 3.5%Inhib. 0% 25% 30% 7%
* short preincubation in presence of antibody (1.5 hour)
no. of eggs penetrated x 100
SPA% (percent of sperm penetration) = ------------------
no. of eggs inseminated 
total no. of swollen head
PI (penetration index) = ----------------------
no. of egg inseminated
%Inhib. (percent of inhibition) = 100 - %SPA
** Some of these MAbs were sent to another laboratory (Jane 
Rogers, Vanderbilt University, TN) for SPA to confirm the test results
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tight binding by at least 50% (Table 9) . Eight MAbs did not 
significantly reduce sperm binding, although the average 
number of sperm bound was decreased compared to the control.
In Vitro Cervical Mucus Penetration Assay
In vitro cervical mucus (CM) penetration tests were 
conducted to examine whether any inhibition of penetration 
occurs due to antibody binding to sperm. A significant 
reduction of penetration was considered when the distance of 
penetration was less than 20 mm. None of these MAbs impeded 
sperm CM penetration (Table 10) .
Determination of Whether a Carbohydrate Moiety was involved 
on the Sperm Surface
Destruction of carbohydrate components on the sperm 
surface was done by treating methanol-fixed sperm with 
sodium metaperiodate; then ELISAs were performed by the 
usual procedure and the effect of damage to carbohydrate 
antigen on MAb binding was examined (Table 11). A concen­
tration dependent response to periodate oxidation was ob­
served with three MAbs (DH200, DH202, and DH203), although 
the antigenicity of these MAbs was retained in some degree.
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TABLE 9 HUMAN SPERM/ZONA TIGHT BINDING TEST:
HEMIZONA ASSAY (HZA)
MAbs HZAa indexb HZA inhibition
INHIBITORS DH3 19% 81%
OF ZONA DH4 27% 73%





NONINHIBITORS DH22 80% 2 0%
OF ZONA DHF5 6 6% 34%
BINDINGd DHTolP3C9 53% 47%
DH113 57% 43%




a The hemizona assay-two to six pairs of HZ were assessed 
for each MAb
no. of tight bound sperm on test zona x 100
bHZI(hemizona index) ----------------------------------
no. of tight bound sperm on control zona
c INHIBITING: HZI< 50 
d NONINHIBITING: HZA> 50
These MAbs were also sent to another laboratory (Jane 
Rogers, Vanderbilt University, TN) to repeat the HZA assay 
and to confirm the test results.
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TABLE 10 IN VITRO CERVICAL MUCUS PENETRATION ASSAY
















* sperm incubated with ascites from NS-1 (non-antibody 
secreting cell line) and used as negative control.
** distance penetrated >25mm means no inhibition.
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TABLE 11
PERCENT OF INHIBITION OF ANTI-HUMAN SPERM ANTIBODIES BINDING 
AFTER DESTRUCTION OF CARBOHYDRATE MOIETY ON SPERM MEMBRANE 
BY




H I B I T 
Treated
I 0 N
control lOmM 25nM 50mM lOOmM 200mM
DH3 0% 0% 0% 0% 0% 0%
DH4 0% 0% 0% 0% 0% 0%
DH13 0% 0% 0% 0% 0% 0%
DH14 0% 0% 0% 0% 0% 0%
DH21 0% 0% 0% 0% 0% 0%
DH22 0% 0% 0% 0% 0% 0%
DH113 0% 0% 0% 0% 0% 0%
DHF5 0% 0% 0% 0% 0% 0%
DH2 00 0% 18% 28% 6 8% 84% 84%
DH2 01 0% 0% 0% 0% 0% 0%
DH202 0% 70% 80% 84% 8 6% 8 6%
DH203 0% 13% 39% 40% 63% 63%
DH205 0% 0% 0% 0% 0% 0%
DHTB11 0% 0% 0% 0% 0% 0%
DHTolP3C9 0% 0% 0% 0% 0% 0%
100 x test. O.D
% inhibition = 100 - ------ ---------------
control O.D
[Three separate assays were done and MAbs ran in duplicate 
in each time, then average of all test results was taken for 
percent of inhibition calculation].
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Passive Immunization
Two MAbs were selected for a passive immunization in 
order to evaluate whether they reduced fertility in mice. 
These two antibodies were selected for passive immunization 
experiment based on their cross reactivity with mouse sperm, 
location of reacting antigens on sperm, and inhibition of 
any other sperm functional tests in vitro (sperm immobiliza­
tion and sperm agglutination). No significant reduction of 
fertility was found compared to control (Table 12).
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TABLE 12 IN VIVO SPERM FUNCTIONAL TEST:
PASSIVE IMMUNIZATION








DH201 T / Ac + /- +/+ no significant inhibition compared 
to control
DH203 Ac,T / H + /+ +/+ no significant inhibition compared 
to control
T(tail), Ac(acrosome), H(head), SA/SI(sperm agglutination 
assay/sperm immobilization assay), Ag(antigen)
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CHAPTER 7
DISCUSSION
In this study, splenic plasma cells from immunized mice 
producing human antisperm antibodies were successfully fused 
with myeloma cells to produce monoclonal antibodies (MAbs). 
Two extraction techniques were used for sperm membrane 
antigen isolation. The first technique involved NP-40 
detergent for antigen extraction from swim-up (motile frac­
tion) human ejaculated sperm and the second technique em­
ployed homogenized human testis for antigen extraction. We 
used pooled ejaculates from several normal human donors for 
antigen extraction procedures to reduce some possible indi­
vidual variations of sperm membrane components. Swim-up 
sperm were all motile and likely to be those sperm associat­
ed with fertilization. By using swim-up washed sperm rather 
than only washed sperm, we did eliminate some non-motile 
sperm and also a population of round cells, including germ 
cells and white blood cells which are not important for 
fertilization but present in ejaculates of normal men. 
Another comparison study from our laboratory (Gupta et al., 
1990) suggested that swim-up sperm rather than thrice-washed 
sperm are far more appropriate for studies of sperm antigens 
associated with motile sperm.
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The results of ELISA and immunobead tests (both on live 
sperm) indicated that we successfully isolated human sperm 
membrane surface antigens from these extraction procedures, 
and by using these extracts as immunogens, we developed some 
sperm membrane specific monoclonal antibodies. The human 
testicular antigen extraction procedure used in this study 
for immunizing mice also showed a promising approach for 
developing antisperm MAbs. The one advantage of these MAbs 
is that since they reacted with testicular sperm, as well as 
ejaculated sperm, they can be used in the cDNA testis li­
brary available for large scale preparation of corresponding 
antigen for contraceptive vaccine development.
The results of the immunofluorescence and immunochemical 
staining studies on methanol-fixed sperm indicated that 
these antibodies recognized antigens on the plasma membrane 
overlaying different regions of the sperm. It has been 
reported by many researchers (Hansen and Hjort, 1971;
Jeffery and Parish, 1972) that naturally occurring human 
antisperm antibodies bind to antigens located on the acro­
some, post-acrosome, equatorial, midpiece, and tail. Our 
study also indicated the same profile. Since sperm acro­
somal region plays the central role in sperm-egg interac­
tions, acrosomal antigens seemed of greatest importance. 
Three MAbs (DH3, DH22, and DH203) developed in this study 
reacted to sperm acrosomal antigens and among these MAbs, 
two (DH3 and DH22) impeded sperm-egg interactions.
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When these antisperm monoclonal antibodies were subjected 
to immunohistological and immunofluorescence evaluations 
against an extensive panel of human tissues or cells, no 
cross-reactivity to somatic tissues was observed. Most of 
the antisperm antibodies with sperm functional inhibitory 
properties reported by many researchers have cross-reacted 
with some human somatic tissues or cells and therefore are 
disqualified for contraceptive vaccine use. The absence of 
cross-reactivity to somatic tissues with MAbs developed in 
this study meet one of the important criteria of a primary 
candidate for contraceptive vaccine development as estab­
lished in a WHO workshop.
Human reproductive tissue sections treated with our 
various antisperm MAbs were tested by employing IF and ICS. 
Staining was found on spermatozoa and spermatids in the 
testis; on epididymal epithelium and the sperm in caput-, 
corpus-, and cauda epididymis; components of seminal vesi­
cle; and sperm in the vas deferens. This gives us informa­
tion as to the possible origination of these corresponding 
antigens in the human reproductive system. It has been 
reported (Myles and Primakoff, 1983; Phelps and Myles, 1987) 
that even as early as in the testis, some antigenic sites 
are localized by observing antibody binding to the whole 
cell, whole head, anterior tail, and posterior tail. Eddy 
(1990) and Cameo et al. (1990) reported that surface sites 
and molecules of defined sperm surface domains are complex.
107
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Binding can occur at different times and perhaps via 
different mechanisms. Also, these arrangements are not 
static but can be altered at different stages in sperm 
maturation. Rearrangements of surface molecules can occur 
as a result of external signal and include the creation or 
uncovering of new epitopes on preexisting surface molecules. 
Our data showed that DH13, DH21, DH22, and DHF5 reacted with 
the epididymal factors and that DH4, DH14, and DH2 05 reacted 
with the seminal vesicle factors. DH3, DH113, DH200-203, 
and DHTB11 recognized testis originated antigens but did not 
recognize any epididymal factors. These testicular antigens 
were probably altered or masked at different stages of 
epididymal sperm maturation and then unmasked again on 
ejaculated sperm. On the other hand, DHTolP3C9 did bind to 
a testicular originated antigen, but the antigen appeared to 
remain unchanged during different stages of sperm matura­
tion.
When species cross-reactivity was assessed for a variety 
of other species' spermatozoa, six MAbs cross-reacted with 
monkey sperm and all MAbs reacted with a variety of other 
species' spermatozoa. This wide species-cross-reactivity 
indicates shared antigens in these species and the possibil­
ity of employing experimental animal models to test the use 
of antigenic determinants recognized by these MAbs as birth 
control vaccines. Such a finding is reasonable in light of 
other investigators' studies. Lopo and Vacquir (1980) have
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reported that antisera against sea urchin sperm cross-react 
with surfaces of sperm of 28 species from seven animal 
phyla. Other investigators have also detected the presence 
of common sperm antigens among mammalian species by means of 
MAbs (Feuchter et al. 1981; Gaunt, 1982). They also ob­
served cross-reactivity to mouse-, rat-, rabbit-, and guinea 
pig sperm. Analysis of antibody binding pattern in the IF 
test indicated that segregation of similar sperm-specific 
antigenic determinants into identical domains in the tested 
species might be related to some common sperm function. One 
such sperm antigen is testis-specific lactate dehydrogenase 
(LDH-C4) which has been reported to be antigenically and 
functionally similar in several mammalian sperm (Erickson et 
al., 1975). However, it should kept in mind that MAbs 
recognize only a region of a particular molecule. It is 
therefore possible that other parts of the surface compo­
nents recognized by the cross-reacting MAbs may differ among 
the species, thus altering the function of these components.
When these monoclonals were tested on fresh, capacitat­
ed, and acrosome reacted spermatozoa, DH22 showed differen­
tial reactivity with swim-up sperm as compared to Ca++ 
ionophore treated sperm (acrosome reacted) in ELISA. This 
finding suggests that changes in the recognition of sperma­
tozoa surface antigens during capacitation allowed increased 
or shifted antigen expression. The pattern of antibody 
binding to the sperm also changed. It reacted heavily with
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acrosomal region on acrosome reacted sperm. Primakoff et 
al., (1988) also reported an antigen, PH-20, localized on 
both plasma membrane and inner-acrosomal membrane depending 
on the sperm status. Before the acrosome reaction, this 
antigen was localized to the posterior head surface of the 
sperm. After the acrosome reaction, however, PH-20 migrates 
from the posterior head surface onto the inner acrosomal 
membrane and this migration increases the total amount of 
PH-20 protein on the sperm surface approximately threefold. 
Further studies on antigen migration or unmasking would be 
useful for DH22. Since DH22 showed a brighter binding by IF 
to acrosomal cap region of acrosome reacted sperm, this MAb 
can be used as a marker to identify acrosome reacted sperm 
among the different stages of sperm population. When our 
antibodies were compared with fresh (noncapacitated) and 
capacitated sperm, changes in surface composition were not 
observed as sperm under capacitation since antigens were 
equally detectable on fresh and capacitated sperm, which 
probably suggests that these monoclonals recognize antigens 
common to both fresh and capacitated spermatozoa.
Immunoblot analysis indicated that most of our anti­
sperm MAbs reacted against sperm membrane proteins ranging 
from 14 to 68 KD molecular weight. Primakoff and Myles 
(1983) reported guinea pig sperm head antigens ranging from 
18 to 70 KD. These results may indicate that proteins 
within this molecular weight range are commonly associated
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with sperm plasma membrane. Isahakia and Alexander (1984) 
reported a mouse antihuman sperm MAb, MA3, that reacted 
against human sperm acrosomal antigen with >200 KD. MA3 
showed inhibition of sperm functional assay (agglutination 
and immobilization). Saling (1985) also reported an anti­
sperm MAb, M42, which significantly inhibited mouse fertil­
ization in vitro. This M42 also recognized a high molecular 
weight doublet, 220-240KD, that was specific to spermatozoa. 
In our study we also observed one MAb, DH13, that reacted 
with post acrosome and tail region of human sperm, and 
recognized a high molecular weight protein, >200 KD, however 
it did not show any agglutinating or immobilizing properties 
although it inhibited both the SPA and HZA. Perhaps this 
MAb is associated with sperm zona receptor or egg fusion 
receptor. Four antisperm MAbs that reacted with low and 
medium molecular weight antigens associated with human sperm 
have been reported by different authors, MA24, 20-35 KD (Naz 
et al., 1984a), MA4, 20-35 KD (Isahakia and Alexander,
1984), C11H, 50-60 KD and 20-35 KD (Kallojoki and Suominen, 
1984), and AF-1, 80-90 KD and <20 KD (O'Rand and Irins, 
1984). All of these were against human sperm except AF-1 
which was against rabbit sperm antigen. Among these AF-1 
and MA-24 demonstrated inhibition of at least one sperm 
functional assay. In our study we also observed some MAbs 
that reacted with low molecular weight proteins ranging 14- 
37 KD. Among these MAbs, DH3, DH4, DH21, DH22, DH201, DH202
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also inhibited at least one sperm functional assay. Some of 
these MAbs also reacted with medium molecular weight protein 
bands (50-68 KD) in addition of lower molecular weight 
protein bands (14-45 KD). The WHO task force of antisperm 
MAb provided limited data on the molecular weights of the 
relevant antigens (Anderson et al. 1987). Among those 
antisperm MAbs identified for further investigation as 
antifertility vaccine candidates, S20 (against testicular 
germ cells and intraacrosomal cap) reacted with a low molec­
ular weight protein ranged from 18-34 KD (Herr et al. 1991). 
S20 inhibits sperm-egg interaction. Lee et al. (1991) 
reported two antisperm MAbs reactive against many mammalian 
species' sperm acrosome. MAb HS-11 recognized two polypep­
tide bands in the 35-50 KD range and MAb HS-63 recognized 3 
bands in the 42-50 KD range. Both HS-11 and HS-63 inhibited 
sperm-egg interaction in mouse in vitro. In our study MAb 
DH3 reacted with the acrosome, neck, and tail region of 
human sperm and recognized 14, 25, and 68 KD protein bands. 
DH 22 reacted with an intraacrosomal protein and recognized 
14 and 68 KD bands. Both DH3 and DH22 inhibited sperm/ 
hamster egg interaction and human zona binding. Comparison 
of the data from the WHO report (Anderson et al. 1987) with 
that of our study, it seems as if many lower molecular 
weight proteins are associated with sperm-egg interaction 
but some medium and high molecular wight proteins also can 
participate. It is not surprising that a MAb raised against
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a given antigen can give multiple bands. These results can 
indicate that a MAb could share some common antigenic epi­
topes of different proteins involved with different sperm 
functions. Moreover, SDS can cause breakage to molecules 
thus antigens can be of reduced size in SDS, i.e., 48 KD and 
a 24 KD molecule could indicate such a phenomenon. One of 
our MAb DH21 recognized five bands, 6 8 , 45, 37, 23, and 14 
KD. Here 45 KD band might reduced in size and produced 
another band of 23 KD. This can further studied by using 
nonreducing gels. Perhaps purification and a more detailed 
biochemical characterization of these antigens are necessary 
to illustrate more information.
Employing hybridoma technology, monoclonal antibodies 
developed against human spermatozoa have demonstrated the 
multiplicity of the antigens having a role in the process of 
fertilization. We found that MAbs, DH3, DH13, DH14, DH22, 
and DHT0 IP3C9, significantly inhibited the standard sperm 
penetration assay (SPA) that has been used in most investi­
gations of mammalian sperm-egg fusion. Among our antisperm 
MAbs DH3 and DH13 showed inhibition only when they were 
treated with precapacitated spermatozoa but not with 
postcapacitated spermatozoa. These results support the 
hypothesis that antibody directed against the plasma mem­
brane of sperm can affect the mobility of membrane 
particles, thus impeding or possibly hastening capacitation 
and the acrosome reaction process necessary for sperm-egg
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fusion. Another possibility would be that these antigens 
coated sperm in epididymis but were removed during capacita­
tion so these MAbs did not inhibit SPA when treated with 
postcapacitated sperm. Other researchers also reported 
(Alexander 1988) that some antisperm monoclonal antibodies 
can prevent sperm fusion with hamster eggs when exposed to 
precapacitated human spermatozoa. Although some researchers 
suggested that the sperm acrosomal region is the most potent 
for egg binding and penetration, Naz and associates (1984) 
and Primakoff et al. (1987) reported that MAbs binding to 
the post-acrosome and tail can also block binding and pene­
tration of zona-free hamster eggs by sperm. In our study we 
developed two MAbs (DH13 and DHF5) that recognized the post- 
acrosomal and tail regions on sperm and did inhibit sperm- 
egg fusion. DH3 was found to react to the acrosome, tail 
and neck regions on human sperm, as well as to significantly 
inhibit hamster egg penetration by human spermatozoa (SPA). 
This result suggests that the sperm post-acrosome and tail 
regions are composed of multiple antigens that may have 
different sperm functions in the fertilization process. MAb 
DH22 showed strong inhibition when post-capacitated sperm 
was incubated with this Mab. This result supports our 
previous finding that DH22 strongly reacted with acrosome- 
reacted sperm, particularly on the acrosomal region of 
sperm. DH22 moderately reacted with the equatorial region 
with pre-capacitated and capacitated sperm. Sperm that are
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capable of fusing with eggs are apparently acrosomereacted 
(Yanagimachi, 1981). Some laboratories have also reported 
that the equatorial region of the plasma membrane may also 
be involved in sperm-egg fusion (for review, Yanagimachi, 
1981) . Our study supports this concept because DH22 reacted 
with the equatorial region and showed some inhibition of 
sperm-egg fusion with precapacitated sperm.
The hemizona assay (HZA) was used to measure the effi­
ciency of sperm function to achieve tight binding to the 
zona pellucida in the presence of these MAbs. Use of NS-1 
as a control ascites fluid demonstrated that peritoneal 
fluid proteins did not interfere with the sperm-zona inter­
actions. Use of Fab fragments with the HZA was employed to 
answer any lingering question regarding the effects of 
agglutination. The initial screening procedure used here 
permits the evaluation of large numbers of Mabs. Those that 
are found to have shown some inhibitory effects can be 
evaluated extensively at a later date. Additional studies 
could be done including the antibody dose dependency, the 
removal of excess antibodies and other components (Mahony et 
al., 1990). Seven of our antisperm MAbs (DH3, DH4, DH13, 
DH14, DH21, DHTB11, and DH205) impeded the HZA; all were 
against coating antigens. MAbs DH4, 21, TB11, and 205 did 
affect sperm performance in the HZA but did not affect the 
SPA. These results support our previous findings that these 
corresponding antigens are available only during the process
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of capacitation but are unrecognizable or absent from sperm 
head once the sperm are predominately acrosome reacted.
These MAbs may be specific for a portion of the zona binding 
receptor. Such antibodies are thought to reduce zona bind­
ing of sperm by obscuring the receptor site/steric hindrance 
(Singer et al., 1985; Alexander, 1990). MAbs DH3 and DH13 
strikingly impeded HZA binding as well as decreased the SPA 
when precapacitated sperm were used. These results indicate 
that these MAbs may be covering a portion of the receptor 
involveed in zona binding; sperm penetration can be inhib­
ited by preventing the acrosome reaction as capacitation 
occurrs. However, the SPA assesses other events i.e., 
sperm-egg fusion and decondensation of nuclear material in 
addition to the ability to spontaneously acrosome react over 
time.
Cervical mucus (CM) penetration is another important 
sperm function known to be inhibited by sperm antibodies 
(Fjallbrant, 1969). Kremer (1982), Hendry et al (1982), and 
Clarke (1988) reported that only sperm bound antibodies of 
IgA class are associated with poor CM penetration in vitro, 
but sperm bound IgG class antibodies do not appear to be 
associated with poor CM penetration. Sperm surface IgA 
class immunoglobulins adhere to the glycoproteins of the 
cervical mucus and impair sperm penetration (Kremer and 
Jager, 1980). Wang et al. (1985) reported that, in the 
presence of sperm, surface tail-tip antibodies of either IgA
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and IgG classes did not interfere with sperm penetration of 
human cervical mucus. Therefore, we can assume that proba­
bly both the immunoglobulin class and the region of binding 
on sperm are important in determining the degree of impair­
ment of fertility in men with sperm antibodies. All of our 
fifteen MAbs were either IgM or IgG class, and none of these 
Mabs showed any inhibition of CM penetration.
When periodic acid treated sperm were used for ELISA, 
result showed that binding of MAbs DH200 and DH202 to sperm 
surface antigens was inhibited severely, and DH203 inhibited 
binding moderately, suggesting that these sperm antigens may 
be composed of carbohydrate as a major moiety, and peptide 
as a minor moiety. Isojima et al. (1990) reported three 
MAbs (H6-3c4, 2B6, and 2E5) against human sperm coating 
antigens. The antigenicity was completely destroyed by 
treating with periodate, but the antigenicity to MAbs 2C6 
was retained in some degree compared to other MAbs. Their 
suggestion was the antigenic epitope of MAbs H6-4C4 may be 
glycolipid, but that of MAb 2C6 may be composed of carbohy­
drate and peptide as major and minor moieties, respectively. 
Other researchers from our laboratory have also reported 
that some complex carbohydrate antigens are associated with 
the sperm cell surface (Kurpisz et al., 1989).
Studies of a few female sera (Ingerslev, 1979; Isojima 
et al., 1972) have revealed that sperm-agglutinating 
antibodies and sperm-immobilizing antibodies can be either
117
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
of the IgM- or the IgG-class, although the majority of sperm 
immobilizing antibodies belong to the IgG class (Isojima, 
1989). All our sperm agglutinating MAbs belonged to the IgG 
class, as did our three immobilizing MAbs. Since sperm 
SA/SI antibodies in patients and experimental animals are 
polyclonal antibodies, production of monoclonal antibodies 
with SA/SI activities is essential to analyze the antigenic 
epitopes of corresponding antigens. In 1980, Isojima et 
al., reported a rat-mouse heterohybridoma, IC4, against 
human seminal plasma which secreted a strong SI-Mab. But 
this antigen does not seem to be a good candidate for immu­
nological contraception because the antigenicity is shared 
with human milk protein. The Isojima group also produced 
some mouse MAbs possessing SA- and Sl-activities, but all 
were human seminal plasma antigen specific. In our study 
none of the four MAbs with SA- and SI- activities reacted 
with human seminal plasma, but did react with sperm membrane 
integral antigen. So, they are against a sperm membrane 
integral antigen rather than sperm coating antigen originat­
ing from seminal plasma.
The absence of cross-reactivity to somatic tissues 
coupled with inhibition of at least one sperm functional 
test by antisperm surface antibodies sperm is one of the 
important criteria of a primary candidate for contraceptive 
vaccine development as established by the WHO in a 
Monoclonal Antibody Workshop (Anderson et al., 1987). Eight
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of our monoclonal antisperm antibodies were able to inhibit 
at least one in vitro sperm functional test and showed no 
cross reactivity with human somatic tissues. Further puri­
fication of these antigens and analyzation of the antigenic 
epitopes and biochemical characterization would be of inter­
est to better understand their immunocontraceptive poten­
tial.
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CHAPTER 8
CONCLUSIONS
1. NP-40 detergent can extract surface protein (both 
coating and integral) from sperm membrane. Using this 
extracted protein as immunogen is a successful approach 
to produce sperm surface-specific monoclonal antibodies.
2. We have developed one hundred thirty monoclonal 
antisperm antibodies and, among these, fifteen have been 
characterized. These fifteen do not cross-react with 
human somatic cells but react with sperm and germinal 
cell components of the male reproductive system, 
indicating their sperm specificity. This fulfills one 
of the important criteria for contraceptive vaccine use 
reported by the WHO Monoclonal Antibody Workshop. Four 
of our MAbs are reactive to epididymal factors, three 
are reactive to seminal vesicle factors, and seven
are reactive to testicular factors.
3. Eight of our monoclonal antisperm antibodies were able 
to inhibit at least one in vitro sperm functional test 
which also meets another criteria of immunocontracep- 
tion. These MAbs can be used to isolate sperm
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antigens for biochemical characterization or can be used 
for cDNA testis libraries for production of sperm 
membrane antigens to better understand their immuno- 
contraceptive potential.
4. MAbs against a coating antigen affected the in vitro 
sperm penetration assay suggesting importance of sperm 
surface interaction with the egg and egg vestments.
5. Since a significant number of women with infertility of 
undetermined etiology have elevated titers of antisperm 
antibodies capable of inducing sperm agglutination or 
immobilization in their sera and cervical fluids, MAbs 
DH200-203 (sperm agglutinating and/or immobilizing 
antibodies) can be used for corresponding antigen 
isolation and biochemical characterization to better 
understand their role in immunocontraception.
6 . Since one MAb (DH22) is capable of binding to
the acrosomal cap region of acrosome reacted sperm, this 
MAb can be used as a marker to identify acrosomal react­
ed sperm among the different stages of sperm population.
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TABLE A Spermatozoa! Auto- and Iso-Antigen












mainly by their location
Two glycoproteins, widely 
distributed in the membrane.
One antigen restricted to the tail 
end piece.
In the post-acrosomal area of the 
plasma membrane and in seminal 
plasma.
In acrosome, including equatorial 
segment.
In acrosome.
In nucleus and seminal plasma.
Protamine l and 2 in sperm nucleus
In acrosome, equatorial segment, 
postnuclear area, main tail piece, 
and tail end piece.
139











































o t>rtf *oP 8
f7 r j  r ?  r j  ^  ^  ^  ^dd fid dddddddd
4  4  41 4  41 41 4  41 +1 +1 4  4  4  4  I I +  +  +  I I +  I I I I | | | | + | 4
I I + +1 +1 + + + + + I I + + +| +| I I +| + + + | | | | | | | jI I
+1 +1 + I I I +1 I I +1 I +1 + 4- I I I I +| +| + + +| | | + | +| | | |
I I I +  I +  +  +  +  +  +  + + 1 +  +  + + I + I  | | | | | | | | j | +  |
+  + +  + I  +  I I I 1 4  4  4  4  1 | +  +  + |  ) | | | | | | | | | ) +
+ I + + I + + I + + I 4- + + I +| + + + + + + | | +| +| +| +| I +| 4|
4 1 4 4 4 4 4 4  4 1 4 4 4  1 4 4 4 4  I 4 4 4 4 4  I I I I I I I + + +|
+ +I+I + ++I+I I +1+1+ I +1 I +| I I 41 4 41 +1 +1 I I 41 I +1 I 41 I I I
c-c-c-r-.r-r-.t^c-r-
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S33 Hen MHS-3 36,37 + + + - + - _ +
S34 Isojlma 2C6 2GB A ll 3 8 3 9 + - + - - - - - ( E )
S3S Kolde YWK-1 40,41,42 + - + - - + - +
S36 Lee 11HS-11 43,44 + + + + + + + ±
S37 Lee 11HS-63 43,44 + + + - - + + - ( E )
S38 Lee HHS-80 43,44 + + + - - - — +
S39 Lee 11HS-85 43,44 + + + - - - — +
S40 Wang NRIFP-1 45,46 + + - - - + -
S41 Wang NRIFP-2 45,46 - + - + - - — +
S42 Wang NRIFP-3 45,46 - + - - + - — +
S43 Wang NRIFP-4 45,46 - - - - ± - _ - ( E )
S44 Wang NRIFP-S 45,46 - - + + - - _ +
S45 Wang NRIFP-6 45,46 - - - + - - _ +
S46 Wang NR1FP-7 45,46 + - + + - ~ +
S47 Wang NR1FP-8 45,46 - - - - - - _ - ( L )
S48 Wang NRIFP-9 45,46 - - - - - - _ +
S49 O’Rand anti RSA 4 7 -5 0 - - - - - - - (E )
S50 Alexander NS.l - - - - - — _ NT
































S57 Sating M29 51,52,53 - - NT - NT NT NT
S58 Mettler SPAG11-13 5 4 -5 8 - + - + + NT NT +
SS9 Mettlcr SPAGV1-2 5 4 -5 8 - + - ‘ + + NT NT -  (L)
S60 Johnson H316 5 3 9 + + + + _ NT NT +
S61 Moore 18.6 60 + + + - - NT NT - ( E )
S62 Moore 60 60 - - - - NT NT -  (L)S63 Moore 64.24 60 - - - + - NT NT - ( L )
S64 Moore 76.11 60 - - - - NT NT -  (L)S65 Moore 97.2S 60 - - - - NT NT - ( L )S66 Moore C-5 60 - - - - NT NT -a )S67 De Ioannes C2E5 61,62 - - + + + NT NT - ( E )S68 DeIoannes 4G2 61,62 — - + + + NT NT - ( L )
®GC, germ cells; IC, interstitial cells.
Vx, vasectomy; SP, seminal plasma.
CL.limited panel: E. extensive oanel: NT. not tested.
